REVELATION BIOSCIENCES, INC. REVB Financial Statement Data


2025 Q2

Submissions

Field Row 1 Row 2 Row 3
adsh 0001213900-25-047104 0001213900-25-045828 0000950170-25-066897
cik 1810560 1810560 1810560
name REVELATION BIOSCIENCES, INC. REVELATION BIOSCIENCES, INC. REVELATION BIOSCIENCES, INC.
sic 2834 2834 2834
countryba US US US
stprba CA CA CA
cityba SAN DIEGO SAN DIEGO SAN DIEGO
zipba 92122 92122 92122
bas1 4660 LAJOLLA VILLAGE DRIVE 4660 LAJOLLA VILLAGE DRIVE 4660 LAJOLLA VILLAGE DRIVE
bas2 SUITE 100 SUITE 100 SUITE 100
baph 650-800-3717 650-800-3717 650-800-3717
countryma US US US
stprma CA CA CA
cityma SAN DIEGO SAN DIEGO SAN DIEGO
zipma 92122 92122 92122
mas1 4660 LAJOLLA VILLAGE DRIVE 4660 LAJOLLA VILLAGE DRIVE 4660 LAJOLLA VILLAGE DRIVE
mas2 SUITE 100 SUITE 100 SUITE 100
countryinc US US US
stprinc DE DE DE
ein 843898466 843898466 843898466
former PETRA ACQUISITION INC. PETRA ACQUISITION INC. PETRA ACQUISITION INC.
changed 20200423 20200423 20200423
afs 4-NON 4-NON 4-NON
wksi 0 0 0
fye 1231 1231 1231
form S-1/A S-1 10-Q
period 20250331 20250331 20250331
fy 2025
fp Q1
filed 20250523 20250520 20250508
accepted 2025-05-23 09:56:00.0 2025-05-20 14:20:00.0 2025-05-08 16:02:00.0
prevrpt 0 0 0
detail 1 1 1
instance ea0243185-s1a1_revelation_htm.xml ea0241635-s1_revelation_htm.xml revb-20250331_htm.xml
nciks 1 1 1
aciks

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
cik Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings.
name Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date.
sic Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business.
countryba The ISO 3166-1 country of the registrant's business address.
stprba The state or province of the registrant’s business address, if field countryba is US or CA.
cityba The city of the registrant's business address.
zipba The zip code of the registrant’s business address.
bas1 The first line of the street of the registrant’s business address.
bas2 The second line of the street of the registrant’s business address.
baph The phone number of the registrant’s business address.
countryma The ISO 3166-1 country of the registrant's mailing address.
stprma The state or province of the registrant’s mailing address, if field countryma is US or CA.
cityma The city of the registrant's mailing address.
zipma The zip code of the registrant’s mailing address.
mas1 The first line of the street of the registrant’s mailing address.
mas2 The second line of the street of the registrant’s mailing address.
countryinc The ISO 3166-1 country of incorporation for the registrant.
stprinc The state or province of incorporation for the registrant, if countryinc is US or CA.
ein Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States.
former Most recent former name of the registrant, if any.
changed Date of change from the former name, if any.
afs Filer status with the SEC at the time of submission:
1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned.
wksi Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement.
fye Fiscal Year End Date, rounded to nearest month-end.
form The submission type of the registrant’s filing.
period Balance Sheet Date, rounded to nearest month-end.
fy Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8).
fp Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year.
filed The date of the registrant’s filing with the Commission.
accepted The acceptance date and time of the registrant’s filing with the Commission.
prevrpt Previous Report – TRUE indicates that the submission information was subsequently amended.
detail TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount).
instance The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol.
nciks Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing.
aciks Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information.

Numbers

adsh ddate tag value uom qtrs version segments coreg footnote
0001213900-25-045828 20241231 Accounts Payable Current 783621.0000 USD 0 us-gaap/2024
0000950170-25-066897 20240331 Alternative Cashless Exercise Of Common Stock Warrants 57589.0000 USD 1 0000950170-25-066897 Class Of Stock= Common Class C; Equity Components= Additional Paid In Capital;
0000950170-25-066897 20250331 Commitments And Contingencies USD 0 us-gaap/2024
0000950170-25-066897 20250331 Common Stock Shares Authorized 500000000.0000 shares 0 us-gaap/2024
0000950170-25-066897 20250331 Common Stock Shares Issued 963796.0000 shares 0 us-gaap/2024
0000950170-25-066897 20241231 Common Stock Value 522.0000 USD 0 us-gaap/2024
0000950170-25-066897 20250331 Disposal Of Lab Supplies 6721.0000 USD 1 0000950170-25-066897
0000950170-25-066897 20250331 Earnings Per Share Basic -2.1100 USD 1 us-gaap/2024
0000950170-25-066897 20250331 Liabilities And Stockholders Equity 3970271.0000 USD 0 us-gaap/2024
0000950170-25-066897 20240331 Net Cash Provided By Used In Investing Activities -19172.0000 USD 1 us-gaap/2024
0000950170-25-066897 20250331 Net Cash Provided By Used In Operating Activities -2794407.0000 USD 1 us-gaap/2024
0000950170-25-066897 20240331 Noncash Issuance Of Common Stock Warrants 6269684.0000 USD 1 0000950170-25-066897 Equity Components= Class D Common Stock Warrants; Subsidiary Sale Of Stock= February2024 Public Offering;
0000950170-25-066897 20240331 Payments To Acquire Property Plant And Equipment 19172.0000 USD 1 us-gaap/2024
0000950170-25-066897 20250331 Research And Development Expense 858830.0000 USD 1 us-gaap/2024
0000950170-25-066897 20240331 Share Based Compensation 32094.0000 USD 1 us-gaap/2024
0000950170-25-066897 20250331 Share Based Compensation 223455.0000 USD 1 us-gaap/2024
0000950170-25-066897 20240331 Shares Outstanding 102007.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-066897 20250331 Stockholders Equity -42556723.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-066897 20240331 Stock Issued During Period Shares New Issues 8029.0000 shares 1 us-gaap/2024 Equity Components= Common Stock; Subsidiary Sale Of Stock= February2024 Public Offering;
0000950170-25-066897 20250331 Weighted Average Number Of Shares Outstanding Basic 3.0000 shares 1 us-gaap/2024 Award Type= Rollover Restricted Stock Unit Awards;
0001213900-25-045828 20231231 Accrued Liabilities Current 1152460.0000 USD 0 us-gaap/2024
0001213900-25-045828 20231231 Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-045828 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 32094.0000 USD 1 us-gaap/2024
0001213900-25-045828 20231231 Alternative Cashless Exercise Of Common Stock Warrants USD 4 0001213900-25-045828 Equity Components= Retained Earnings;
0001213900-25-045828 20241231 Alternative Cashless Exercise Of Common Stock Warrants USD 4 0001213900-25-045828 Equity Components= Retained Earnings;
0001213900-25-045828 20240331 Alternative Cashless Of Common Stock Warrants Exercise 57589.0000 USD 1 0001213900-25-045828 Equity Components= Class C Common Stock Warrant;
0001213900-25-045828 20231231 Assets 12212609.0000 USD 0 us-gaap/2024
0001213900-25-045828 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 3704611.0000 USD 0 us-gaap/2024
0001213900-25-045828 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect 2560039.0000 USD 1 us-gaap/2024
0001213900-25-045828 20250331 Common Stock Shares Issued 963796.0000 shares 0 us-gaap/2024
0001213900-25-045828 20250331 Common Stock Shares Outstanding 963796.0000 shares 0 us-gaap/2024
0001213900-25-045828 20240331 Earnings Per Share Diluted -39.3700 USD 1 us-gaap/2024
0001213900-25-045828 20241231 Earnings Per Share Diluted -87.6800 USD 4 us-gaap/2024
0001213900-25-045828 20231231 Fair Value Adjustment Of Warrants -8328937.0000 USD 4 us-gaap/2024
0001213900-25-045828 20241231 Increase Decrease In Accrued Liabilities -2935920.0000 USD 4 us-gaap/2024
0001213900-25-045828 20250331 Increase Decrease In Prepaid Deferred Expense And Other Assets 156571.0000 USD 1 us-gaap/2024
0001213900-25-045828 20250331 Liabilities And Stockholders Equity 3970271.0000 USD 0 us-gaap/2024
0001213900-25-045828 20231231 Net Income Loss -120254.0000 USD 4 us-gaap/2024
0001213900-25-045828 20240331 Net Income Loss USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-045828 20240331 Net Income Loss -2681433.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-045828 20250331 Net Income Loss USD 1 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045828 20231231 Noncash Fair Value Of Common Stock Warrants With Warrant Inducement USD 4 0001213900-25-045828 Equity Components= Class E Common Stock Warrants;
0001213900-25-045828 20241231 Noncash Fair Value Of New Common Stock Warrants With Public Offering USD 4 0001213900-25-045828 Equity Components= Class C Common Stock Warrant; Subsidiary Sale Of Stock= February2023 Public Offering;
0001213900-25-045828 20241231 Nonoperating Income Expense -7063427.0000 USD 4 us-gaap/2024
0001213900-25-045828 20241231 Operating Expenses 7975109.0000 USD 4 us-gaap/2024
0001213900-25-045828 20231231 Pre Funded Warrants Exercise 33.0000 USD 4 0001213900-25-045828 Equity Components= Additional Paid In Capital;
0001213900-25-045828 20241231 Pre Funded Warrants Exercise 127.0000 USD 4 0001213900-25-045828
0001213900-25-045828 20241231 Pre Funded Warrants Exercise Shares 77282.0000 shares 4 0001213900-25-045828 Equity Components= Common Stock;
0001213900-25-045828 20230131 Proceeds From Issuance Initial Public Offering 14000000.0000 USD 0 us-gaap/2024
0001213900-25-045828 20240831 Proceeds From Warrant Exercises 3800000.0000 USD 0 us-gaap/2024 Equity Components= Class E Common Stock Warrants;
0001213900-25-045828 20241231 Proceeds From Warrant Exercises 3501276.0000 USD 4 us-gaap/2024 Equity Components= Warrant Inducement;
0001213900-25-045828 20231231 Property Plant And Equipment Net 65084.0000 USD 0 us-gaap/2024
0001213900-25-045828 20250331 Research And Development Expense 858830.0000 USD 1 us-gaap/2024
0001213900-25-045828 20221231 Shares Outstanding 1.0000 shares 0 us-gaap/2024 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-045828 20240331 Shares Outstanding 102007.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045828 20250331 Shares Outstanding 963796.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045828 20221231 Stockholders Equity 5.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045828 20231231 Stockholders Equity 32114552.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital; Restatement= Scenario Previously Reported;
0001213900-25-045828 20231231 Stockholders Equity -25467102.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-045828 20241231 Stockholders Equity 45213498.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-045828 20240131 Stock Issued During Period Shares New Issues 77282.0000 shares 0 us-gaap/2024 Class Of Stock= Common Stock; Equity Components= Class D Pre Funded Warrants;
0001213900-25-045828 20241130 Stock Issued During Period Shares New Issues 4064040.0000 shares 0 us-gaap/2024 Equity Components= Class F Common Stock Warrants;
0001213900-25-045828 20241231 Stock Issued During Period Value Issued For Services 1.0000 USD 4 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045828 20231231 Stock Issued During Period Value New Issues 33474.0000 USD 4 us-gaap/2024 Class Of Stock= February2023 Public Offering;
0001213900-25-045828 20231231 Stock Issued During Period Value New Issues USD 4 us-gaap/2024 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-045828 20241231 Stock Issued During Period Value New Issues USD 4 us-gaap/2024 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-045828 20231231 Stock Issued During Period Value Restricted Stock Award Gross USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-045828 20231231 Stock Issued During Period Value Retrospective Application Of Reverse Recapitalization USD 4 0001213900-25-045828 Restatement= Scenario Previously Reported;
0001213900-25-045828 20241231 Stock Issued During Period Value Retrospective Application Of Reverse Recapitalization USD 4 0001213900-25-045828 Restatement= Scenario Previously Reported;
0001213900-25-045828 20241231 Weighted Average Number Of Diluted Shares Outstanding 171510.0000 shares 4 us-gaap/2024
0001213900-25-045828 20250331 Weighted Average Number Of Shares Outstanding Basic 971313.0000 shares 1 us-gaap/2024
0001213900-25-047104 20231231 Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock USD 4 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-047104 20231231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 4 us-gaap/2024 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-047104 20231231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-047104 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-047104 20241231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 168850.0000 USD 4 us-gaap/2024
0001213900-25-047104 20241231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 4 us-gaap/2024 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-047104 20241231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 168850.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-047104 20241231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-047104 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 223455.0000 USD 1 us-gaap/2024
0001213900-25-047104 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 223455.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-047104 20231231 Alternative Cashless Exercise Of Common Stock Warrants USD 4 0001213900-25-047104 Equity Components= Retained Earnings;
0001213900-25-047104 20241231 Alternative Cashless Exercise Of Common Stock Warrants USD 4 0001213900-25-047104 Equity Components= Retained Earnings;
0001213900-25-047104 20250331 Alternative Cashless Exercise Of Common Stock Warrants Shares 383005.0000 shares 1 0001213900-25-047104 Class Of Stock= Class F Common Stock Warrants; Equity Components= Common Stock;
0001213900-25-047104 20240331 Alternative Cashless Of Common Stock Warrants Exercise 57589.0000 USD 1 0001213900-25-047104 Equity Components= Class C Common Stock Warrant;
0001213900-25-047104 20250331 Assets 3970271.0000 USD 0 us-gaap/2024
0001213900-25-047104 20231231 Cash And Cash Equivalents At Carrying Value 11991701.0000 USD 0 us-gaap/2024
0001213900-25-047104 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 14551740.0000 USD 0 us-gaap/2024
0001213900-25-047104 20231231 Common Stock Shares Authorized 500000000.0000 shares 0 us-gaap/2024
0001213900-25-047104 20241231 Common Stock Shares Authorized 500000000.0000 shares 0 us-gaap/2024
0001213900-25-047104 20241231 Common Stock Shares Issued 522223.0000 shares 0 us-gaap/2024
0001213900-25-047104 20241231 Common Stock Shares Issued 5160.0000 shares 0 us-gaap/2024 Equity Components= Class C Common Stock Warrant;
0001213900-25-047104 20231231 Deferred Offering Costs 71133.0000 USD 0 us-gaap/2024
0001213900-25-047104 20241231 Depreciation 27923.0000 USD 4 us-gaap/2024
0001213900-25-047104 20231231 Earnings Per Share Basic -8.4400 USD 4 us-gaap/2024
0001213900-25-047104 20241231 Fair Value Adjustment Of Warrants 100000.0000 USD 4 us-gaap/2024 Equity Components= Class C Common Stock Warrant;
0001213900-25-047104 20231231 Increase Decrease In Accounts Payable 749660.0000 USD 4 us-gaap/2024
0001213900-25-047104 20240331 Increase Decrease In Accounts Payable 321767.0000 USD 1 us-gaap/2024
0001213900-25-047104 20231231 Increase Decrease In Accrued Liabilities 161963.0000 USD 4 us-gaap/2024
0001213900-25-047104 20240331 Increase Decrease In Accrued Liabilities -532180.0000 USD 1 us-gaap/2024
0001213900-25-047104 20250331 Increase Decrease In Accrued Liabilities -664168.0000 USD 1 us-gaap/2024
0001213900-25-047104 20231231 Increase Decrease In Prepaid Deferred Expense And Other Assets 11559.0000 USD 4 us-gaap/2024
0001213900-25-047104 20231231 Liabilities And Stockholders Equity 12212609.0000 USD 0 us-gaap/2024
0001213900-25-047104 20241231 Net Cash Provided By Used In Investing Activities -19171.0000 USD 4 us-gaap/2024
0001213900-25-047104 20231231 Net Cash Provided By Used In Operating Activities -7286286.0000 USD 4 us-gaap/2024
0001213900-25-047104 20250331 Net Income Loss USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-047104 20231231 Noncash Fair Value Of Common Stock Warrants With Warrant Inducement USD 4 0001213900-25-047104 Equity Components= Class E Common Stock Warrants;
0001213900-25-047104 20240331 Operating Income Loss -1902138.0000 USD 1 us-gaap/2024
0001213900-25-047104 20240331 Pre Funded Warrants Exercise USD 1 0001213900-25-047104 Class Of Stock= Common Class D; Equity Components= Retained Earnings;
0001213900-25-047104 20231231 Proceeds From Warrant Exercises 34.0000 USD 4 us-gaap/2024 Equity Components= Class C Pre Funded Warrants;
0001213900-25-047104 20250331 Proceeds From Warrant Exercises USD 1 us-gaap/2024 Equity Components= Class D Pre Funded Warrants;
0001213900-25-047104 20241231 Shares Outstanding 522223.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-047104 20221231 Stockholders Equity USD 0 us-gaap/2024 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock; Restatement= Scenario Previously Reported;
0001213900-25-047104 20221231 Stockholders Equity 26399296.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-047104 20231231 Stockholders Equity 6647715.0000 USD 0 us-gaap/2024
0001213900-25-047104 20240331 Stockholders Equity 9473145.0000 USD 0 us-gaap/2024
0001213900-25-047104 20241231 Stockholders Equity 522.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-047104 20230131 Stock Issued During Period Shares New Issues 6017.0000 shares 0 us-gaap/2024
0001213900-25-047104 20230131 Stock Issued During Period Shares New Issues 699.0000 shares 0 us-gaap/2024 Equity Components= Class C Pre Funded Warrants;
0001213900-25-047104 20241231 Stock Issued During Period Shares New Issues 6217640.0000 shares 3 us-gaap/2024 Equity Components= Class C Common Stock Warrant;
0001213900-25-047104 20231231 Stock Issued During Period Shares Restricted Stock Award Gross shares 4 us-gaap/2024 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-047104 20231231 Stock Issued During Period Shares Restricted Stock Award Gross 8.0000 shares 4 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-047104 20241231 Stock Issued During Period Value Issued For Services 24999.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-047104 20231231 Stock Issued During Period Value New Issues 33469.0000 USD 4 us-gaap/2024 Class Of Stock= February2023 Public Offering; Equity Components= Additional Paid In Capital;
0001213900-25-047104 20240331 Stock Issued During Period Value New Issues 5417045.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-047104 20241231 Stock Issued During Period Value New Issues 5417045.0000 USD 4 us-gaap/2024 Class Of Stock= February2024 Public Offering; Equity Components= Additional Paid In Capital;
0001213900-25-047104 20231231 Stock Issued During Period Value Restricted Stock Award Gross USD 4 us-gaap/2024 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-047104 20231231 Stock Issued During Period Value Retrospective Application Of Reverse Recapitalization USD 4 0001213900-25-047104 Restatement= Scenario Previously Reported;
0001213900-25-047104 20241231 Stock Issued During Period Value Retrospective Application Of Reverse Recapitalization 249.0000 USD 4 0001213900-25-047104 Equity Components= Additional Paid In Capital; Restatement= Scenario Previously Reported;
0001213900-25-047104 20241231 Stock Issued During Period Value Retrospective Application Of Reverse Recapitalization USD 4 0001213900-25-047104 Restatement= Scenario Previously Reported;
0001213900-25-047104 20231231 Stock Redeemed Or Called During Period Shares -1.0000 shares 4 us-gaap/2024 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-047104 20241231 Warrant Inducement Exercises USD 4 0001213900-25-047104 Class Of Stock= Common Class D; Equity Components= Retained Earnings;
0001213900-25-047104 20241231 Warrant Inducement Exercises Shares 254002.0000 shares 4 0001213900-25-047104 Class Of Stock= Class E Common Stock Warrants; Equity Components= Common Stock;
0001213900-25-047104 20241231 Warrant Liability 2246.0000 USD 0 0001213900-25-047104
0001213900-25-047104 20250331 Weighted Average Number Of Shares Outstanding Basic 125000.0000 shares 1 us-gaap/2024 Equity Components= Class F Common Stock Warrants;
0000950170-25-066897 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 32094.0000 USD 1 us-gaap/2024
0000950170-25-066897 20250331 Additional Paid In Capital 45436511.0000 USD 0 us-gaap/2024
0000950170-25-066897 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 32094.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-066897 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 223455.0000 USD 1 us-gaap/2024
0000950170-25-066897 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 223455.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-066897 20250331 Assets 3970271.0000 USD 0 us-gaap/2024
0000950170-25-066897 20241231 Common Stock Shares Issued 522223.0000 shares 0 us-gaap/2024
0000950170-25-066897 20240331 Depreciation 6262.0000 USD 1 us-gaap/2024
0000950170-25-066897 20250331 Fair Value Adjustment Of Warrants -1417.0000 USD 1 us-gaap/2024
0000950170-25-066897 20250331 Increase Decrease In Accounts Payable -158563.0000 USD 1 us-gaap/2024
0000950170-25-066897 20240331 Increase Decrease In Accrued Liabilities -532180.0000 USD 1 us-gaap/2024
0000950170-25-066897 20241231 Liabilities Current 1913667.0000 USD 0 us-gaap/2024
0000950170-25-066897 20240331 Net Cash Provided By Used In Operating Activities -2837969.0000 USD 1 us-gaap/2024
0000950170-25-066897 20250331 Net Income Loss -2051085.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-066897 20240331 Operating Income Loss -1902138.0000 USD 1 us-gaap/2024
0000950170-25-066897 20250331 Other Nonoperating Income Expense 42485.0000 USD 1 us-gaap/2024
0000950170-25-066897 20250331 Retained Earnings Accumulated Deficit -42556723.0000 USD 0 us-gaap/2024
0000950170-25-066897 20240331 Stockholders Equity 9473145.0000 USD 0 us-gaap/2024
0000950170-25-066897 20240331 Stock Issued During Period Value New Issues 8.0000 USD 1 us-gaap/2024 Equity Components= Common Stock; Subsidiary Sale Of Stock= February2024 Public Offering;
0000950170-25-066897 20250331 Warrant Liability 829.0000 USD 0 0000950170-25-066897
0000950170-25-066897 20240331 Weighted Average Number Of Diluted Shares Outstanding 68115.0000 shares 1 us-gaap/2024
0000950170-25-066897 20250331 Weighted Average Number Of Shares Outstanding Basic 125000.0000 shares 1 us-gaap/2024 Equity Components= Class F Common Stock Warrants;
0000950170-25-066897 20241231 Assets 6622049.0000 USD 0 us-gaap/2024
0000950170-25-066897 20250331 Increase Decrease In Accrued Liabilities -664168.0000 USD 1 us-gaap/2024
0000950170-25-066897 20250331 Net Income Loss -2051085.0000 USD 1 us-gaap/2024
0000950170-25-066897 20240331 Nonoperating Income Expense -779295.0000 USD 1 us-gaap/2024
0000950170-25-066897 20250331 Nonoperating Income Expense 43902.0000 USD 1 us-gaap/2024
0000950170-25-066897 20240331 Operating Expenses 1902138.0000 USD 1 us-gaap/2024
0000950170-25-066897 20250331 Operating Expenses 2094987.0000 USD 1 us-gaap/2024
0000950170-25-066897 20250331 Operating Income Loss -2094987.0000 USD 1 us-gaap/2024
0000950170-25-066897 20240331 Proceeds From Warrant Exercises 127.0000 USD 1 us-gaap/2024 Equity Components= Class D Pre Funded Warrants;
0000950170-25-066897 20241231 Property Plant And Equipment Net 56332.0000 USD 0 us-gaap/2024
0000950170-25-066897 20240331 Research And Development Expense 717582.0000 USD 1 us-gaap/2024
0000950170-25-066897 20231231 Shares Outstanding 16484.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-066897 20231231 Stockholders Equity 6647715.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0000950170-25-066897 20240331 Stockholders Equity -28148535.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-066897 20241231 Stockholders Equity 4708382.0000 USD 0 us-gaap/2024
0000950170-25-066897 20241231 Stockholders Equity 522.0000 USD 0 us-gaap/2024 Equity Components= Common Stock; Restatement= Scenario Previously Reported;
0000950170-25-066897 20250331 Stock Issued During Period Shares New Issues 191503.0000 shares 1 us-gaap/2024 Equity Components= Class F Common Stock Warrants;
0000950170-25-066897 20250331 Stock Issued During Period Shares Restricted Stock Award Gross 58568.0000 shares 1 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-066897 20250331 Stock Issued During Period Value Restricted Stock Award Gross -59.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-066897 20240331 Pre Funded Warrants Exercise 49.0000 USD 1 0000950170-25-066897 Class Of Stock= Common Class D; Equity Components= Additional Paid In Capital;
0000950170-25-066897 20240331 Alternative Cashless Exercise Of Common Stock Warrants 0.0000 USD 1 0000950170-25-066897 Class Of Stock= Common Class C; Equity Components= Common Stock;
0000950170-25-066897 20250331 Alternative Cashless Exercise Of Common Stock Warrants -383.0000 USD 1 0000950170-25-066897 Class Of Stock= Class F Common Stock Warrants; Equity Components= Additional Paid In Capital;
0000950170-25-066897 20250331 Assets Current 3927881.0000 USD 0 us-gaap/2024
0000950170-25-066897 20250331 Cash And Cash Equivalents At Carrying Value 3704611.0000 USD 0 us-gaap/2024
0000950170-25-066897 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 14551740.0000 USD 0 us-gaap/2024
0000950170-25-066897 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect -2794407.0000 USD 1 us-gaap/2024
0000950170-25-066897 20241231 Common Stock Shares Authorized 500000000.0000 shares 0 us-gaap/2024
0000950170-25-066897 20250331 Depreciation 7221.0000 USD 1 us-gaap/2024
0000950170-25-066897 20250331 General And Administrative Expense 1236157.0000 USD 1 us-gaap/2024
0000950170-25-066897 20240331 Increase Decrease In Accounts Payable 321767.0000 USD 1 us-gaap/2024
0000950170-25-066897 20241231 Liabilities 1913667.0000 USD 0 us-gaap/2024
0000950170-25-066897 20240331 Net Income Loss -2681433.0000 USD 1 us-gaap/2024
0000950170-25-066897 20241231 Prepaid Expense And Other Assets Current 66699.0000 USD 0 us-gaap/2024
0000950170-25-066897 20240331 Proceeds From Issuance Initial Public Offering 5417053.0000 USD 1 us-gaap/2024 Subsidiary Sale Of Stock= February2024 Public Offering;
0000950170-25-066897 20250331 Stockholders Equity 2880752.0000 USD 0 us-gaap/2024
0000950170-25-066897 20240331 Stock Issued During Period Value New Issues 5417045.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital; Subsidiary Sale Of Stock= February2024 Public Offering;
0000950170-25-066897 20241231 Accrued Liabilities Current 1127800.0000 USD 0 us-gaap/2024
0000950170-25-066897 20250331 Alternative Cashless Exercise Of Common Stock Warrants Shares 383005.0000 shares 1 0000950170-25-066897 Class Of Stock= Class F Common Stock Warrants; Equity Components= Common Stock;
0000950170-25-066897 20240331 Alternative Cashless Of Common Stock Warrants Exercise 57589.0000 USD 1 0000950170-25-066897 Equity Components= Class C Common Stock Warrant;
0000950170-25-066897 20241231 Cash And Cash Equivalents At Carrying Value 6499018.0000 USD 0 us-gaap/2024
0000950170-25-066897 20230131 Common Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2024
0000950170-25-066897 20250331 Common Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2024
0000950170-25-066897 20250331 Common Stock Shares Outstanding 963796.0000 shares 0 us-gaap/2024
0000950170-25-066897 20250331 Fair Value Adjustment Of Warrants 1417.0000 USD 1 us-gaap/2024 Equity Components= Class C Common Stock Warrant;
0000950170-25-066897 20240331 Increase Decrease In Prepaid Deferred Expense And Other Assets -12815.0000 USD 1 us-gaap/2024
0000950170-25-066897 20240331 Net Cash Provided By Used In Financing Activities 5417180.0000 USD 1 us-gaap/2024
0000950170-25-066897 20240331 Net Income Loss -2681433.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-066897 20240331 Other Nonoperating Income Expense -847722.0000 USD 1 us-gaap/2024
0000950170-25-066897 20240331 Pre Funded Warrants Exercise Shares 77282.0000 shares 1 0000950170-25-066897 Class Of Stock= Common Class D; Equity Components= Common Stock;
0000950170-25-066897 20250331 Prepaid Expense And Other Assets Current 223270.0000 USD 0 us-gaap/2024
0000950170-25-066897 20240131 Proceeds From Issuance Initial Public Offering 5400000.0000 USD 0 us-gaap/2024
0000950170-25-066897 20241231 Retained Earnings Accumulated Deficit -40505638.0000 USD 0 us-gaap/2024
0000950170-25-066897 20240131 Stock Issued During Period Shares New Issues 85311.0000 shares 0 us-gaap/2024
0000950170-25-066897 20240331 Stock Issued During Period Value New Issues 5417053.0000 USD 1 us-gaap/2024 Subsidiary Sale Of Stock= February2024 Public Offering;
0000950170-25-066897 20250331 Accounts Payable Current 625058.0000 USD 0 us-gaap/2024
0000950170-25-066897 20250331 Accrued Liabilities Current 463632.0000 USD 0 us-gaap/2024
0000950170-25-066897 20230131 Common Stock Shares Authorized 500000000.0000 shares 0 us-gaap/2024 Range= Maximum;
0000950170-25-066897 20240331 Earnings Per Share Basic -39.3700 USD 1 us-gaap/2024
0000950170-25-066897 20250331 Earnings Per Share Diluted -2.1100 USD 1 us-gaap/2024
0000950170-25-066897 20240331 Increase Decrease In Deferred Offering Costs -71133.0000 USD 1 0000950170-25-066897
0000950170-25-066897 20250331 Liabilities 1089519.0000 USD 0 us-gaap/2024
0000950170-25-066897 20250331 Liabilities Current 1089519.0000 USD 0 us-gaap/2024
0000950170-25-066897 20240331 Pre Funded Warrants Exercise 127.0000 USD 1 0000950170-25-066897 Class Of Stock= Common Class D;
0000950170-25-066897 20250331 Property Plant And Equipment Net 42390.0000 USD 0 us-gaap/2024
0000950170-25-066897 20250331 Shares Outstanding 963796.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-066897 20231231 Stockholders Equity 32114801.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-066897 20250331 Weighted Average Number Of Diluted Shares Outstanding 971313.0000 shares 1 us-gaap/2024
0000950170-25-066897 20240331 Weighted Average Number Of Shares Outstanding Basic 68115.0000 shares 1 us-gaap/2024
0000950170-25-066897 20241231 Accounts Payable Current 783621.0000 USD 0 us-gaap/2024
0000950170-25-066897 20241231 Additional Paid In Capital 45213498.0000 USD 0 us-gaap/2024
0000950170-25-066897 20240331 Alternative Cashless Exercise Of Common Stock Warrants 57589.0000 USD 1 0000950170-25-066897 Class Of Stock= Common Class C;
0000950170-25-066897 20240331 Alternative Cashless Exercise Of Common Stock Warrants Shares 212.0000 shares 1 0000950170-25-066897 Class Of Stock= Common Class C; Equity Components= Common Stock;
0000950170-25-066897 20241231 Assets Current 6565717.0000 USD 0 us-gaap/2024
0000950170-25-066897 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 11991701.0000 USD 0 us-gaap/2024
0000950170-25-066897 20241231 Common Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2024
0000950170-25-066897 20241231 Common Stock Shares Outstanding 522223.0000 shares 0 us-gaap/2024
0000950170-25-066897 20240331 Fair Value Adjustment Of Warrants -68427.0000 USD 1 us-gaap/2024
0000950170-25-066897 20250331 Increase Decrease In Prepaid Deferred Expense And Other Assets 156571.0000 USD 1 us-gaap/2024
0000950170-25-066897 20240331 Stockholders Equity 102.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-066897 20241231 Stockholders Equity 45213498.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-066897 20250331 Alternative Cashless Exercise Of Common Stock Warrants 383.0000 USD 1 0000950170-25-066897 Class Of Stock= Class F Common Stock Warrants; Equity Components= Common Stock;
0000950170-25-066897 20250331 Alternative Cashless Of Common Stock Warrants Exercise 3094680.0000 USD 1 0000950170-25-066897 Equity Components= Class F Common Stock Warrants;
0000950170-25-066897 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 6499018.0000 USD 0 us-gaap/2024
0000950170-25-066897 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 3704611.0000 USD 0 us-gaap/2024
0000950170-25-066897 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect 2560039.0000 USD 1 us-gaap/2024
0000950170-25-066897 20241231 Commitments And Contingencies USD 0 us-gaap/2024
0000950170-25-066897 20250331 Common Stock Value 964.0000 USD 0 us-gaap/2024
0000950170-25-066897 20240331 Earnings Per Share Diluted -39.3700 USD 1 us-gaap/2024
0000950170-25-066897 20240331 Fair Value Adjustment Of Warrants 68427.0000 USD 1 us-gaap/2024 Equity Components= Class C Common Stock Warrant;
0000950170-25-066897 20240331 General And Administrative Expense 1184556.0000 USD 1 us-gaap/2024
0000950170-25-066897 20241231 Liabilities And Stockholders Equity 6622049.0000 USD 0 us-gaap/2024
0000950170-25-066897 20240331 Pre Funded Warrants Exercise 78.0000 USD 1 0000950170-25-066897 Class Of Stock= Common Class D; Equity Components= Common Stock;
0000950170-25-066897 20241231 Shares Outstanding 522223.0000 shares 0 us-gaap/2024 Equity Components= Common Stock; Restatement= Scenario Previously Reported;
0000950170-25-066897 20231231 Stockholders Equity 16.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-066897 20231231 Stockholders Equity -25467102.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-066897 20240331 Stockholders Equity 37621578.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-066897 20241231 Stockholders Equity -40505638.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-066897 20250331 Stockholders Equity 45436511.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-066897 20250331 Stockholders Equity 964.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-066897 20250331 Stock Issued During Period Value Restricted Stock Award Gross 59.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-066897 20241231 Warrant Liability 2246.0000 USD 0 0000950170-25-066897
0000950170-25-066897 20250331 Weighted Average Number Of Shares Outstanding Basic 971313.0000 shares 1 us-gaap/2024
0001213900-25-045828 20241231 Common Stock Shares Outstanding 522223.0000 shares 0 us-gaap/2024
0001213900-25-045828 20241231 Accrued Liabilities Current 1127800.0000 USD 0 us-gaap/2024
0001213900-25-045828 20231231 Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock USD 4 us-gaap/2024
0001213900-25-045828 20231231 Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-045828 20240331 Alternative Cashless Exercise Of Class F Common Stock Warrants USD 1 0001213900-25-045828 Equity Components= Class F Common Stock Warrants;
0001213900-25-045828 20241231 Alternative Cashless Exercise Of Common Stock Warrants 57589.0000 USD 4 0001213900-25-045828
0001213900-25-045828 20231231 Alternative Cashless Exercise Of Common Stock Warrants Shares shares 4 0001213900-25-045828 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-045828 20241231 Alternative Cashless Exercise Of Common Stock Warrants Shares 212.0000 shares 4 0001213900-25-045828 Equity Components= Common Stock;
0001213900-25-045828 20241231 Alternative Cashless Of Common Stock Warrants Exercise 57589.0000 USD 4 0001213900-25-045828
0001213900-25-045828 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect 6738722.0000 USD 4 us-gaap/2024
0001213900-25-045828 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect -2794407.0000 USD 1 us-gaap/2024
0001213900-25-045828 20241231 Common Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2024
0001213900-25-045828 20241231 Common Stock Shares Issued 522223.0000 shares 0 us-gaap/2024
0001213900-25-045828 20241231 Common Stock Warrants Exercises Shares 6312.0000 shares 4 0001213900-25-045828 Class Of Stock= Common Class D; Equity Components= Common Stock;
0001213900-25-045828 20231231 Deferred Underwriting Commissions 2911260.0000 USD 0 0001213900-25-045828
0001213900-25-045828 20231231 Depreciation 25049.0000 USD 4 us-gaap/2024
0001213900-25-045828 20231231 Earnings Per Share Diluted -8.4400 USD 4 us-gaap/2024
0001213900-25-045828 20231231 General And Administrative Expense 4510762.0000 USD 4 us-gaap/2024
0001213900-25-045828 20250331 Increase Decrease In Accrued Liabilities -664168.0000 USD 1 us-gaap/2024
0001213900-25-045828 20240331 Net Cash Provided By Used In Financing Activities 5417180.0000 USD 1 us-gaap/2024
0001213900-25-045828 20240331 Net Income Loss USD 1 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045828 20241231 Noncash Equity Issuance Costs In Connection With Warrant Inducement Included In Accounts Payable 25968.0000 USD 4 0001213900-25-045828
0001213900-25-045828 20241231 Noncash Fair Value Of Common Stock Warrants With Warrant Inducement 939679.0000 USD 4 0001213900-25-045828 Equity Components= Class D Common Stock Warrants;
0001213900-25-045828 20241231 Payments For Repurchase Of Redeemable Preferred Stock USD 4 us-gaap/2024
0001213900-25-045828 20250331 Payments To Acquire Property Plant And Equipment USD 1 us-gaap/2024
0001213900-25-045828 20231231 Pre Funded Warrants Exercise 1.0000 USD 4 0001213900-25-045828 Equity Components= Common Stock;
0001213900-25-045828 20240331 Pre Funded Warrants Exercise 127.0000 USD 1 0001213900-25-045828 Class Of Stock= Common Class D;
0001213900-25-045828 20241231 Pre Funded Warrants Exercise 78.0000 USD 4 0001213900-25-045828 Equity Components= Common Stock;
0001213900-25-045828 20250331 Prepaid Expense And Other Assets Current 223270.0000 USD 0 us-gaap/2024
0001213900-25-045828 20231231 Proceeds From Issuance Initial Public Offering USD 4 us-gaap/2024 Subsidiary Sale Of Stock= February2024 Public Offering;
0001213900-25-045828 20240131 Proceeds From Issuance Initial Public Offering 5400000.0000 USD 0 us-gaap/2024
0001213900-25-045828 20240331 Proceeds From Issuance Initial Public Offering 5417053.0000 USD 1 us-gaap/2024 Subsidiary Sale Of Stock= February2024 Public Offering;
0001213900-25-045828 20231231 Proceeds From Warrant Exercises USD 4 us-gaap/2024 Equity Components= Warrant Inducement;
0001213900-25-045828 20241130 Proceeds From Warrant Exercises 4100000.0000 USD 0 us-gaap/2024 Equity Components= Class F Common Stock Warrants And The Class G Common Stock Warrants;
0001213900-25-045828 20241231 Proceeds From Warrant Exercises 3687918.0000 USD 4 us-gaap/2024 Equity Components= Class E Common Stock Warrants;
0001213900-25-045828 20231231 Retained Earnings Accumulated Deficit -25467102.0000 USD 0 us-gaap/2024
0001213900-25-045828 20221231 Stockholders Equity USD 0 us-gaap/2024 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-045828 20221231 Stockholders Equity 77.0000 USD 0 us-gaap/2024 Equity Components= Common Stock; Restatement= Scenario Previously Reported;
0001213900-25-045828 20231231 Stockholders Equity 6647715.0000 USD 0 us-gaap/2024
0001213900-25-045828 20231231 Stockholders Equity USD 0 us-gaap/2024 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-045828 20240331 Stockholders Equity -28148535.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-045828 20241231 Stockholders Equity 4708382.0000 USD 0 us-gaap/2024
0001213900-25-045828 20241231 Stockholders Equity USD 0 us-gaap/2024 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-045828 20241231 Stock Issued During Period Shares Issued For Services 653.0000 shares 4 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045828 20231231 Stock Issued During Period Shares New Issues shares 4 us-gaap/2024 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-045828 20240131 Stock Issued During Period Shares New Issues 85311.0000 shares 0 us-gaap/2024
0001213900-25-045828 20241231 Stock Issued During Period Shares New Issues 5160.0000 shares 3 us-gaap/2024 Equity Components= Class C Common Stock Warrant; Subsidiary Sale Of Stock= Two Thousand Twenty Three Public Offering;
0001213900-25-045828 20241231 Stock Issued During Period Shares New Issues 8029.0000 shares 4 us-gaap/2024 Class Of Stock= February2024 Public Offering; Equity Components= Common Stock;
0001213900-25-045828 20230430 Stock Issued During Period Shares Restricted Stock Award Gross 8.0000 shares 0 us-gaap/2024 Award Type= Restricted Stock;
0001213900-25-045828 20231231 Stock Issued During Period Shares Restricted Stock Award Gross 8.0000 shares 4 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045828 20241231 Stock Issued During Period Value Issued For Services USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-045828 20250331 Stock Issued During Period Value Other 59.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045828 20241231 Stock Issued During Period Value Retrospective Application Of Reverse Recapitalization USD 4 0001213900-25-045828 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock; Restatement= Scenario Previously Reported;
0001213900-25-045828 20241231 Warrant Inducement Exercises Shares 159249.0000 shares 4 0001213900-25-045828 Class Of Stock= Common Class D; Equity Components= Common Stock;
0001213900-25-045828 20241231 Warrant Inducement Exercises Shares shares 4 0001213900-25-045828 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-045828 20241231 Weighted Average Number Of Shares Outstanding Basic 171510.0000 shares 4 us-gaap/2024
0001213900-25-045828 20250331 Additional Paid In Capital 45436511.0000 USD 0 us-gaap/2024
0001213900-25-047104 20250331 Accounts Payable Current 625058.0000 USD 0 us-gaap/2024
0001213900-25-047104 20250331 Accrued Liabilities Current 463632.0000 USD 0 us-gaap/2024
0001213900-25-047104 20231231 Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-047104 20231231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 155721.0000 USD 4 us-gaap/2024
0001213900-25-047104 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-047104 20240331 Alternative Cashless Exercise Of Common Stock Warrants 57589.0000 USD 1 0001213900-25-047104 Class Of Stock= Common Class C; Equity Components= Additional Paid In Capital;
0001213900-25-047104 20231231 Assets 12212609.0000 USD 0 us-gaap/2024
0001213900-25-047104 20230131 Common Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-047104 20250331 Common Stock Shares Authorized 500000000.0000 shares 0 us-gaap/2024
0001213900-25-047104 20250331 Common Stock Shares Issued 963796.0000 shares 0 us-gaap/2024
0001213900-25-047104 20241231 Deferred Offering Costs USD 0 us-gaap/2024
0001213900-25-047104 20240331 Disposal Of Lab Supplies USD 1 0001213900-25-047104
0001213900-25-047104 20250331 Earnings Per Share Diluted -2.1100 USD 1 us-gaap/2024
0001213900-25-047104 20241231 Fair Value Adjustment Of Warrants -81441.0000 USD 4 us-gaap/2024
0001213900-25-047104 20241231 Increase Decrease In Deferred Offering Costs -71133.0000 USD 4 0001213900-25-047104
0001213900-25-047104 20250331 Liabilities And Stockholders Equity 3970271.0000 USD 0 us-gaap/2024
0001213900-25-047104 20250331 Liabilities Current 1089519.0000 USD 0 us-gaap/2024
0001213900-25-047104 20240331 Net Income Loss USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-047104 20241231 Noncash Fair Value Of Common Stock Warrants 2066429.0000 USD 4 0001213900-25-047104 Equity Components= Class G Common Stock Warrants;
0001213900-25-047104 20241231 Operating Income Loss -7975109.0000 USD 4 us-gaap/2024
0001213900-25-047104 20241231 Pre Funded Warrants Exercise 49.0000 USD 4 0001213900-25-047104 Equity Components= Additional Paid In Capital;
0001213900-25-047104 20231231 Research And Development Expense 4145902.0000 USD 4 us-gaap/2024
0001213900-25-047104 20250331 Research And Development Expense 858830.0000 USD 1 us-gaap/2024
0001213900-25-047104 20250331 Share Based Compensation 223455.0000 USD 1 us-gaap/2024
0001213900-25-047104 20240331 Shares Outstanding 102007.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-047104 20221231 Stockholders Equity 1052453.0000 USD 0 us-gaap/2024
0001213900-25-047104 20221231 Stockholders Equity 1052453.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001213900-25-047104 20231231 Stockholders Equity 265.0000 USD 0 us-gaap/2024 Equity Components= Common Stock; Restatement= Scenario Previously Reported;
0001213900-25-047104 20250331 Stockholders Equity -42556723.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-047104 20240131 Stock Issued During Period Shares New Issues 77282.0000 shares 0 us-gaap/2024 Class Of Stock= Common Stock; Equity Components= Class D Pre Funded Warrants;
0001213900-25-047104 20240131 Stock Issued During Period Shares New Issues 2730000.0000 shares 0 us-gaap/2024 Equity Components= Class D Common Stock Warrant;
0001213900-25-047104 20250228 Stock Issued During Period Shares New Issues 3064040.0000 shares 0 us-gaap/2024 Equity Components= Class F Common Stock Warrants; Subsequent Event Type= Subsequent Event;
0001213900-25-047104 20231231 Stock Issued During Period Shares Reverse Stock Split Fractional Stock Round Up -23.0000 shares 4 0001213900-25-047104 Equity Components= Common Stock; Restatement= Scenario Previously Reported;
0001213900-25-047104 20231231 Stock Issued During Period Value New Issues 5.0000 USD 4 us-gaap/2024 Class Of Stock= February2023 Public Offering; Equity Components= Common Stock;
0001213900-25-047104 20240331 Stock Issued During Period Value New Issues USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-047104 20231231 Stock Issued During Period Value Retrospective Application Of Reverse Recapitalization USD 4 0001213900-25-047104 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock; Restatement= Scenario Previously Reported;
0001213900-25-047104 20231231 Stock Issued During Period Value Retrospective Application Of Reverse Recapitalization 72.0000 USD 4 0001213900-25-047104 Equity Components= Additional Paid In Capital; Restatement= Scenario Previously Reported;
0001213900-25-047104 20241231 Stock Issued During Period Value Retrospective Application Of Reverse Recapitalization USD 4 0001213900-25-047104 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock; Restatement= Scenario Previously Reported;
0001213900-25-047104 20241231 Warrant Inducement Exercises 3501276.0000 USD 4 0001213900-25-047104 Class Of Stock= Common Class D;
0001213900-25-047104 20241231 Warrant Inducement Exercises 3501117.0000 USD 4 0001213900-25-047104 Class Of Stock= Common Class D; Equity Components= Additional Paid In Capital;
0001213900-25-047104 20241231 Warrant Inducement Exercises USD 4 0001213900-25-047104 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-047104 20250331 Weighted Average Number Of Diluted Shares Outstanding 971313.0000 shares 1 us-gaap/2024
0001213900-25-047104 20240331 Weighted Average Number Of Shares Outstanding Basic 68115.0000 shares 1 us-gaap/2024
0001213900-25-047104 20250331 Weighted Average Number Of Shares Outstanding Basic 3.0000 shares 1 us-gaap/2024 Award Type= Rollover Restricted Stock Unit Awards;
0001213900-25-045828 20231231 Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock USD 4 us-gaap/2024 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-045828 20250331 Alternative Cashless Exercise Of Class F Common Stock Warrants 3094680.0000 USD 1 0001213900-25-045828 Equity Components= Class F Common Stock Warrants;
0001213900-25-045828 20241231 Alternative Cashless Exercise Of Common Stock Warrants 57589.0000 USD 4 0001213900-25-045828 Equity Components= Additional Paid In Capital;
0001213900-25-045828 20250331 Alternative Cashless Exercise Of Common Stock Warrants USD 1 0001213900-25-045828 Class Of Stock= Class F Common Stock Warrants;
0001213900-25-045828 20250331 Alternative Cashless Exercise Of Common Stock Warrants USD 1 0001213900-25-045828 Class Of Stock= Class F Common Stock Warrants; Equity Components= Retained Earnings;
0001213900-25-045828 20231231 Alternative Cashless Of Common Stock Warrants Exercise 5526287.0000 USD 4 0001213900-25-045828
0001213900-25-045828 20241231 Cash And Cash Equivalents At Carrying Value 6499018.0000 USD 0 us-gaap/2024
0001213900-25-045828 20250331 Cash And Cash Equivalents At Carrying Value 3704611.0000 USD 0 us-gaap/2024
0001213900-25-045828 20221231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 5252979.0000 USD 0 us-gaap/2024
0001213900-25-045828 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 6499018.0000 USD 0 us-gaap/2024
0001213900-25-045828 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect -5492683.0000 USD 4 us-gaap/2024
0001213900-25-045828 20241231 Common Stock Warrants Exercises Shares shares 4 0001213900-25-045828 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-045828 20241231 Deferred Underwriting Commissions USD 0 0001213900-25-045828
0001213900-25-045828 20240331 Depreciation 6262.0000 USD 1 us-gaap/2024
0001213900-25-045828 20250331 Depreciation 7221.0000 USD 1 us-gaap/2024
0001213900-25-045828 20240331 Disposal Of Lab Supplies USD 1 0001213900-25-045828
0001213900-25-045828 20241231 Earnings Per Share Basic -87.6800 USD 4 us-gaap/2024
0001213900-25-045828 20250331 Fair Value Adjustment Of Warrants 1417.0000 USD 1 us-gaap/2024 Equity Components= Class C Common Stock Warrant;
0001213900-25-045828 20241231 General And Administrative Expense 4426113.0000 USD 4 us-gaap/2024
0001213900-25-045828 20241231 Liabilities And Stockholders Equity 6622049.0000 USD 0 us-gaap/2024
0001213900-25-045828 20241231 Liabilities Current 1913667.0000 USD 0 us-gaap/2024
0001213900-25-045828 20250331 Liabilities Current 1089519.0000 USD 0 us-gaap/2024
0001213900-25-045828 20231231 Net Cash Provided By Used In Financing Activities 14025008.0000 USD 4 us-gaap/2024
0001213900-25-045828 20250331 Net Cash Provided By Used In Financing Activities USD 1 us-gaap/2024
0001213900-25-045828 20241231 Net Cash Provided By Used In Operating Activities -18321276.0000 USD 4 us-gaap/2024
0001213900-25-045828 20231231 Net Income Loss USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-045828 20231231 Net Income Loss -120254.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-045828 20241231 Net Income Loss USD 4 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045828 20241231 Noncash Fair Value Of Common Stock Warrants 2066429.0000 USD 4 0001213900-25-045828 Equity Components= Class G Common Stock Warrants;
0001213900-25-045828 20231231 Noncash Fair Value Of New Common Stock Warrants With Public Offering 13996500.0000 USD 4 0001213900-25-045828 Equity Components= Class C Common Stock Warrant; Subsidiary Sale Of Stock= February2023 Public Offering;
0001213900-25-045828 20231231 Operating Expenses 8656664.0000 USD 4 us-gaap/2024
0001213900-25-045828 20231231 Other Nonoperating Income Expense 207473.0000 USD 4 us-gaap/2024
0001213900-25-045828 20231231 Pre Funded Warrants Exercise 34.0000 USD 4 0001213900-25-045828
0001213900-25-045828 20240331 Pre Funded Warrants Exercise 78.0000 USD 1 0001213900-25-045828 Class Of Stock= Common Class D; Equity Components= Common Stock;
0001213900-25-045828 20241231 Pre Funded Warrants Exercise USD 4 0001213900-25-045828 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-045828 20241231 Pre Funded Warrants Exercise 49.0000 USD 4 0001213900-25-045828 Equity Components= Additional Paid In Capital;
0001213900-25-045828 20231231 Proceeds From Issuance Initial Public Offering 14029974.0000 USD 4 us-gaap/2024 Subsidiary Sale Of Stock= February2023 Public Offering;
0001213900-25-045828 20241231 Proceeds From Issuance Initial Public Offering USD 4 us-gaap/2024 Subsidiary Sale Of Stock= February2023 Public Offering;
0001213900-25-045828 20231231 Proceeds From Warrant Exercises USD 4 us-gaap/2024 Equity Components= Class D Common Stock Warrants;
0001213900-25-045828 20241231 Proceeds From Warrant Exercises 241390.0000 USD 4 us-gaap/2024 Equity Components= Class D Common Stock Warrants;
0001213900-25-045828 20250331 Property Plant And Equipment Net 42390.0000 USD 0 us-gaap/2024
0001213900-25-045828 20241231 Shares Outstanding shares 0 us-gaap/2024 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-045828 20221231 Stockholders Equity 1052453.0000 USD 0 us-gaap/2024
0001213900-25-045828 20221231 Stockholders Equity -25346848.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings; Restatement= Scenario Previously Reported;
0001213900-25-045828 20231231 Stockholders Equity USD 0 us-gaap/2024 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock; Restatement= Scenario Previously Reported;
0001213900-25-045828 20240331 Stockholders Equity 37621578.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-045828 20250331 Stockholders Equity 2880752.0000 USD 0 us-gaap/2024
0001213900-25-045828 20250331 Stockholders Equity 964.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045828 20241231 Stock Issued During Period Shares Issued For Services shares 4 us-gaap/2024 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-045828 20230131 Stock Issued During Period Shares New Issues 6450000.0000 shares 0 us-gaap/2024 Equity Components= Class C Common Stock Warrant;
0001213900-25-045828 20240331 Stock Issued During Period Shares New Issues 8029.0000 shares 1 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045828 20231231 Stock Issued During Period Shares Retrospective Application Of Reverse Recapitalization -72540.0000 shares 4 0001213900-25-045828 Equity Components= Common Stock; Restatement= Scenario Previously Reported;
0001213900-25-045828 20231231 Stock Issued During Period Shares Reverse Stock Split Fractional Stock Round Up -23.0000 shares 4 0001213900-25-045828 Equity Components= Common Stock; Restatement= Scenario Previously Reported;
0001213900-25-045828 20240531 Stock Issued During Period Value Issued For Services 25000.0000 USD 0 us-gaap/2024
0001213900-25-045828 20231231 Stock Issued During Period Value New Issues USD 4 us-gaap/2024 Class Of Stock= February2023 Public Offering; Equity Components= Retained Earnings;
0001213900-25-045828 20240331 Stock Issued During Period Value New Issues 5417053.0000 USD 1 us-gaap/2024
0001213900-25-045828 20240331 Stock Issued During Period Value New Issues 8.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045828 20231231 Stock Issued During Period Value Restricted Stock Award Gross USD 4 us-gaap/2024
0001213900-25-045828 20231231 Stock Issued During Period Value Retrospective Application Of Reverse Recapitalization USD 4 0001213900-25-045828 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock; Restatement= Scenario Previously Reported;
0001213900-25-045828 20231231 Stock Issued During Period Value Retrospective Application Of Reverse Recapitalization -72.0000 USD 4 0001213900-25-045828 Equity Components= Common Stock; Restatement= Scenario Previously Reported;
0001213900-25-045828 20231231 Stock Redeemed Or Called During Period Shares shares 4 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045828 20240331 Weighted Average Number Of Diluted Shares Outstanding 68115.0000 shares 1 us-gaap/2024
0001213900-25-045828 20250331 Weighted Average Number Of Diluted Shares Outstanding 971313.0000 shares 1 us-gaap/2024
0001213900-25-045828 20240331 Weighted Average Number Of Shares Outstanding Basic 68115.0000 shares 1 us-gaap/2024
0001213900-25-047104 20231231 Additional Paid In Capital 32114801.0000 USD 0 us-gaap/2024
0001213900-25-047104 20241231 Additional Paid In Capital 45213498.0000 USD 0 us-gaap/2024
0001213900-25-047104 20231231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 4 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-047104 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 1 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-047104 20250331 Alternative Cashless Exercise Of Common Stock Warrants USD 1 0001213900-25-047104 Class Of Stock= Class F Common Stock Warrants;
0001213900-25-047104 20231231 Alternative Cashless Of Common Stock Warrants Exercise 5526287.0000 USD 4 0001213900-25-047104
0001213900-25-047104 20241231 Assets 6622049.0000 USD 0 us-gaap/2024
0001213900-25-047104 20231231 Assets Current 12147525.0000 USD 0 us-gaap/2024
0001213900-25-047104 20241231 Assets Current 6565717.0000 USD 0 us-gaap/2024
0001213900-25-047104 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 11991701.0000 USD 0 us-gaap/2024
0001213900-25-047104 20231231 Commitments And Contingencies USD 0 us-gaap/2024
0001213900-25-047104 20241231 Common Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2024
0001213900-25-047104 20241231 Common Stock Shares Outstanding 522223.0000 shares 0 us-gaap/2024
0001213900-25-047104 20241231 Common Stock Warrants Exercises Shares shares 4 0001213900-25-047104 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-047104 20241231 Deferred Underwriting Commissions USD 0 0001213900-25-047104
0001213900-25-047104 20250331 Disposal Of Lab Supplies 6721.0000 USD 1 0001213900-25-047104
0001213900-25-047104 20250331 Increase Decrease In Accounts Payable -158563.0000 USD 1 us-gaap/2024
0001213900-25-047104 20231231 Liabilities Current 5564894.0000 USD 0 us-gaap/2024
0001213900-25-047104 20231231 Net Income Loss USD 4 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-047104 20231231 Noncash Fair Value Of Common Stock Warrants USD 4 0001213900-25-047104 Equity Components= Class G Common Stock Warrants;
0001213900-25-047104 20231231 Noncash Fair Value Of New Common Stock Warrants With Public Offering 13996500.0000 USD 4 0001213900-25-047104 Equity Components= Class C Common Stock Warrant; Subsidiary Sale Of Stock= February2023 Public Offering;
0001213900-25-047104 20231231 Nonoperating Income Expense 8536410.0000 USD 4 us-gaap/2024
0001213900-25-047104 20250331 Operating Expenses 2094987.0000 USD 1 us-gaap/2024
0001213900-25-047104 20250331 Operating Income Loss -2094987.0000 USD 1 us-gaap/2024
0001213900-25-047104 20231231 Pre Funded Warrants Exercise 34.0000 USD 4 0001213900-25-047104
0001213900-25-047104 20240331 Pre Funded Warrants Exercise 49.0000 USD 1 0001213900-25-047104 Class Of Stock= Common Class D; Equity Components= Additional Paid In Capital;
0001213900-25-047104 20240331 Pre Funded Warrants Exercise 78.0000 USD 1 0001213900-25-047104 Class Of Stock= Common Class D; Equity Components= Common Stock;
0001213900-25-047104 20241231 Pre Funded Warrants Exercise USD 4 0001213900-25-047104 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-047104 20231231 Proceeds From Issuance Initial Public Offering USD 4 us-gaap/2024 Subsidiary Sale Of Stock= February2024 Public Offering;
0001213900-25-047104 20250331 Proceeds From Issuance Initial Public Offering USD 1 us-gaap/2024 Subsidiary Sale Of Stock= February2024 Public Offering;
0001213900-25-047104 20231231 Proceeds From Warrant Exercises USD 4 us-gaap/2024 Equity Components= Class E Common Stock Warrants;
0001213900-25-047104 20231231 Proceeds From Warrant Exercises USD 4 us-gaap/2024 Equity Components= Warrant Inducement;
0001213900-25-047104 20240331 Proceeds From Warrant Exercises 127.0000 USD 1 us-gaap/2024 Equity Components= Class D Pre Funded Warrants;
0001213900-25-047104 20241231 Proceeds From Warrant Exercises 3687918.0000 USD 4 us-gaap/2024 Equity Components= Class E Common Stock Warrants;
0001213900-25-047104 20241231 Property Plant And Equipment Net 56332.0000 USD 0 us-gaap/2024
0001213900-25-047104 20240331 Research And Development Expense 717582.0000 USD 1 us-gaap/2024
0001213900-25-047104 20221231 Shares Outstanding 1.0000 shares 0 us-gaap/2024 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock; Restatement= Scenario Previously Reported;
0001213900-25-047104 20221231 Shares Outstanding 77375.0000 shares 0 us-gaap/2024 Equity Components= Common Stock; Restatement= Scenario Previously Reported;
0001213900-25-047104 20231231 Shares Outstanding 264537.0000 shares 0 us-gaap/2024 Equity Components= Common Stock; Restatement= Scenario Previously Reported;
0001213900-25-047104 20231231 Stockholders Equity 6647715.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001213900-25-047104 20241231 Stock Issued During Period Shares Issued For Services 653.0000 shares 4 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-047104 20241130 Stock Issued During Period Shares New Issues 6096060.0000 shares 0 us-gaap/2024 Equity Components= Class G Common Stock Warrants;
0001213900-25-047104 20250331 Stock Issued During Period Shares New Issues 191503.0000 shares 1 us-gaap/2024 Equity Components= Class F Common Stock Warrants;
0001213900-25-047104 20230430 Stock Issued During Period Shares Restricted Stock Award Gross 8.0000 shares 0 us-gaap/2024 Award Type= Restricted Stock;
0001213900-25-047104 20231231 Stock Issued During Period Shares Retrospective Application Of Reverse Recapitalization -72540.0000 shares 4 0001213900-25-047104 Equity Components= Common Stock; Restatement= Scenario Previously Reported;
0001213900-25-047104 20241231 Stock Issued During Period Value Issued For Services USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-047104 20250331 Stock Issued During Period Value Other -59.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-047104 20250331 Stock Issued During Period Value Other USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-047104 20231231 Stock Issued During Period Value Restricted Stock Award Gross USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-047104 20241231 Warrant Inducement Exercises 3687918.0000 USD 4 0001213900-25-047104 Class Of Stock= Class E Common Stock Warrants;
0001213900-25-047104 20231231 Warrant Liability 141276.0000 USD 0 0001213900-25-047104
0001213900-25-045828 20231231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 4 us-gaap/2024 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-045828 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 1 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045828 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 223455.0000 USD 1 us-gaap/2024
0001213900-25-045828 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 223455.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-045828 20240331 Alternative Cashless Exercise Of Common Stock Warrants USD 1 0001213900-25-045828 Class Of Stock= Common Class C; Equity Components= Common Stock;
0001213900-25-045828 20241231 Alternative Cashless Exercise Of Common Stock Warrants USD 4 0001213900-25-045828 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-045828 20250331 Alternative Cashless Exercise Of Common Stock Warrants 383.0000 USD 1 0001213900-25-045828 Class Of Stock= Class F Common Stock Warrants; Equity Components= Common Stock;
0001213900-25-045828 20231231 Alternative Cashless Exercise Of Common Stock Warrants Shares 4948.0000 shares 4 0001213900-25-045828 Equity Components= Common Stock;
0001213900-25-045828 20250331 Alternative Cashless Of Common Stock Warrants Exercise USD 1 0001213900-25-045828 Equity Components= Class C Common Stock Warrant;
0001213900-25-045828 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 11991701.0000 USD 0 us-gaap/2024
0001213900-25-045828 20231231 Commitments And Contingencies USD 0 us-gaap/2024
0001213900-25-045828 20241231 Common Stock Shares Issued 5160.0000 shares 0 us-gaap/2024 Equity Components= Class C Common Stock Warrant;
0001213900-25-045828 20231231 Common Stock Shares Outstanding 16484.0000 shares 0 us-gaap/2024
0001213900-25-045828 20241231 Common Stock Value 522.0000 USD 0 us-gaap/2024
0001213900-25-045828 20241231 Common Stock Warrants Exercises USD 4 0001213900-25-045828 Class Of Stock= Common Class D; Equity Components= Retained Earnings;
0001213900-25-045828 20231231 Deferred Offering Costs 71133.0000 USD 0 us-gaap/2024
0001213900-25-045828 20241231 Deferred Offering Costs Included In Accounts Payable And Accrued Expenses USD 4 0001213900-25-045828
0001213900-25-045828 20240331 Earnings Per Share Basic -39.3700 USD 1 us-gaap/2024
0001213900-25-045828 20231231 Increase Decrease In Accounts Payable 749660.0000 USD 4 us-gaap/2024
0001213900-25-045828 20231231 Issuance Of Stock And Warrants For Services Or Claims USD 4 us-gaap/2024
0001213900-25-045828 20241231 Issuance Of Stock And Warrants For Services Or Claims 25000.0000 USD 4 us-gaap/2024
0001213900-25-045828 20250331 Liabilities 1089519.0000 USD 0 us-gaap/2024
0001213900-25-045828 20231231 Net Income Loss USD 4 us-gaap/2024 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-045828 20241231 Net Income Loss USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-045828 20250331 Net Income Loss -2051085.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-045828 20231231 Noncash Fair Value Of Common Stock Warrants USD 4 0001213900-25-045828 Equity Components= Class F Common Stock Warrants;
0001213900-25-045828 20231231 Nonoperating Income Expense 8536410.0000 USD 4 us-gaap/2024
0001213900-25-045828 20240331 Payments To Acquire Property Plant And Equipment 19172.0000 USD 1 us-gaap/2024
0001213900-25-045828 20231231 Pre Funded Warrants Exercise USD 4 0001213900-25-045828 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-045828 20241231 Pre Funded Warrants Exercise Shares shares 4 0001213900-25-045828 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-045828 20241231 Proceeds From Issuance Initial Public Offering 5417053.0000 USD 4 us-gaap/2024 Subsidiary Sale Of Stock= February2024 Public Offering;
0001213900-25-045828 20250331 Proceeds From Issuance Initial Public Offering USD 1 us-gaap/2024 Subsidiary Sale Of Stock= February2024 Public Offering;
0001213900-25-045828 20231231 Proceeds From Warrant Exercises USD 4 us-gaap/2024 Equity Components= Class D Pre Funded Warrants;
0001213900-25-045828 20250331 Proceeds From Warrant Exercises USD 1 us-gaap/2024 Equity Components= Class D Pre Funded Warrants;
0001213900-25-045828 20250331 Retained Earnings Accumulated Deficit -42556723.0000 USD 0 us-gaap/2024
0001213900-25-045828 20231231 Share Based Compensation 155721.0000 USD 4 us-gaap/2024
0001213900-25-045828 20240331 Share Based Compensation 32094.0000 USD 1 us-gaap/2024
0001213900-25-045828 20231231 Shares Outstanding shares 0 us-gaap/2024 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-045828 20221231 Stockholders Equity 26399296.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-045828 20231231 Stockholders Equity 32114801.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-045828 20240131 Stock Issued During Period Shares New Issues 8029.0000 shares 0 us-gaap/2024 Equity Components= Class D Pre Funded Warrants;
0001213900-25-045828 20241231 Stock Issued During Period Shares Retrospective Application Of Reverse Recapitalization shares 4 0001213900-25-045828 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock; Restatement= Scenario Previously Reported;
0001213900-25-045828 20241231 Stock Issued During Period Shares Retrospective Application Of Reverse Recapitalization -248029.0000 shares 4 0001213900-25-045828 Equity Components= Common Stock; Restatement= Scenario Previously Reported;
0001213900-25-045828 20241231 Stock Issued During Period Value Issued For Services USD 4 us-gaap/2024 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-045828 20241231 Stock Issued During Period Value New Issues 5417053.0000 USD 4 us-gaap/2024 Class Of Stock= February2024 Public Offering;
0001213900-25-045828 20241231 Stock Issued During Period Value New Issues 8.0000 USD 4 us-gaap/2024 Class Of Stock= February2024 Public Offering; Equity Components= Common Stock;
0001213900-25-045828 20231231 Stock Issued During Period Value Restricted Stock Award Gross USD 4 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-047104 20231231 Accounts Payable Current 1359898.0000 USD 0 us-gaap/2024
0001213900-25-047104 20231231 Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock USD 4 us-gaap/2024 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-047104 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 32094.0000 USD 1 us-gaap/2024
0001213900-25-047104 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 32094.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-047104 20241231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 4 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-047104 20240331 Alternative Cashless Exercise Of Common Stock Warrants USD 1 0001213900-25-047104 Class Of Stock= Common Class C; Equity Components= Retained Earnings;
0001213900-25-047104 20241231 Alternative Cashless Exercise Of Common Stock Warrants USD 4 0001213900-25-047104 Equity Components= Common Stock;
0001213900-25-047104 20241231 Alternative Cashless Of Common Stock Warrants Exercise 57589.0000 USD 4 0001213900-25-047104
0001213900-25-047104 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 6499018.0000 USD 0 us-gaap/2024
0001213900-25-047104 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 3704611.0000 USD 0 us-gaap/2024
0001213900-25-047104 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect 2560039.0000 USD 1 us-gaap/2024
0001213900-25-047104 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect -5492683.0000 USD 4 us-gaap/2024
0001213900-25-047104 20241231 Commitments And Contingencies USD 0 us-gaap/2024
0001213900-25-047104 20250331 Common Stock Value 964.0000 USD 0 us-gaap/2024
0001213900-25-047104 20241231 Deferred Offering Costs Included In Accounts Payable And Accrued Expenses USD 4 0001213900-25-047104
0001213900-25-047104 20231231 Net Cash Provided By Used In Financing Activities 14025008.0000 USD 4 us-gaap/2024
0001213900-25-047104 20231231 Deferred Underwriting Commissions 2911260.0000 USD 0 0001213900-25-047104
0001213900-25-047104 20240331 Earnings Per Share Diluted -39.3700 USD 1 us-gaap/2024
0001213900-25-047104 20240331 General And Administrative Expense 1184556.0000 USD 1 us-gaap/2024
0001213900-25-047104 20241231 General And Administrative Expense 4426113.0000 USD 4 us-gaap/2024
0001213900-25-047104 20241231 Increase Decrease In Prepaid Deferred Expense And Other Assets -17992.0000 USD 4 us-gaap/2024
0001213900-25-047104 20240331 Issuance Of Class D Common Stock Warrants In Connection With The February2024 Public Offering 6269684.0000 USD 1 0001213900-25-047104 Equity Components= Class D Common Stock Warrants; Subsidiary Sale Of Stock= February2024 Public Offering;
0001213900-25-047104 20231231 Liabilities 5564894.0000 USD 0 us-gaap/2024
0001213900-25-047104 20241231 Liabilities And Stockholders Equity 6622049.0000 USD 0 us-gaap/2024
0001213900-25-047104 20231231 Net Income Loss -120254.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-047104 20241231 Net Income Loss USD 4 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-047104 20241231 Net Income Loss -15038536.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-047104 20250331 Net Income Loss USD 1 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-047104 20231231 Noncash Fair Value Of Common Stock Warrants With Warrant Inducement USD 4 0001213900-25-047104 Equity Components= Class D Common Stock Warrants;
0001213900-25-047104 20231231 Noncash Fair Value Of New Common Stock Warrants With Public Offering USD 4 0001213900-25-047104 Equity Components= Class D Common Stock Warrants; Subsidiary Sale Of Stock= February2024 Public Offering;
0001213900-25-047104 20231231 Operating Income Loss -8656664.0000 USD 4 us-gaap/2024
0001213900-25-047104 20241231 Other Nonoperating Income Expense -7144868.0000 USD 4 us-gaap/2024
0001213900-25-047104 20231231 Payments For Repurchase Of Redeemable Preferred Stock 5000.0000 USD 4 us-gaap/2024
0001213900-25-047104 20241231 Pre Funded Warrants Exercise 127.0000 USD 4 0001213900-25-047104
0001213900-25-047104 20241231 Pre Funded Warrants Exercise Shares 77282.0000 shares 4 0001213900-25-047104 Equity Components= Common Stock;
0001213900-25-047104 20241231 Proceeds From Issuance Initial Public Offering USD 4 us-gaap/2024 Subsidiary Sale Of Stock= February2023 Public Offering;
0001213900-25-047104 20240831 Proceeds From Warrant Exercises 3800000.0000 USD 0 us-gaap/2024 Equity Components= Class E Common Stock Warrants;
0001213900-25-047104 20241231 Proceeds From Warrant Exercises 127.0000 USD 4 us-gaap/2024 Equity Components= Class D Pre Funded Warrants;
0001213900-25-047104 20250331 Shares Outstanding 963796.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-047104 20221231 Stockholders Equity 26399224.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital; Restatement= Scenario Previously Reported;
0001213900-25-047104 20221231 Stockholders Equity -25346848.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings; Restatement= Scenario Previously Reported;
0001213900-25-047104 20231231 Stockholders Equity 16.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-047104 20231231 Stockholders Equity -25467102.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-047104 20231231 Stockholders Equity -25467102.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings; Restatement= Scenario Previously Reported;
0001213900-25-047104 20240331 Stockholders Equity 37621578.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-047104 20241231 Stockholders Equity -40505638.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-047104 20250331 Stockholders Equity 45436511.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-047104 20250331 Stockholders Equity 964.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-047104 20240531 Stock Issued During Period Shares Issued For Services 653.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-047104 20230131 Stock Issued During Period Shares New Issues 6450000.0000 shares 0 us-gaap/2024 Equity Components= Class C Common Stock Warrant;
0001213900-25-047104 20231231 Stock Issued During Period Shares New Issues 6017.0000 shares 4 us-gaap/2024 Class Of Stock= February2023 Public Offering; Equity Components= Common Stock;
0001213900-25-047104 20240831 Stock Issued During Period Shares New Issues 5096120.0000 shares 0 us-gaap/2024 Equity Components= Class E Common Stock Warrants;
0001213900-25-047104 20250331 Stock Issued During Period Shares Other 58568.0000 shares 1 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-047104 20241231 Warrant Inducement Exercises 254.0000 USD 4 0001213900-25-047104 Class Of Stock= Class E Common Stock Warrants; Equity Components= Common Stock;
0001213900-25-047104 20250331 Warrant Liability 829.0000 USD 0 0001213900-25-047104
0001213900-25-047104 20231231 Weighted Average Number Of Diluted Shares Outstanding 14246.0000 shares 4 us-gaap/2024
0001213900-25-047104 20241231 Weighted Average Number Of Diluted Shares Outstanding 171510.0000 shares 4 us-gaap/2024
0001213900-25-047104 20250331 Weighted Average Number Of Shares Outstanding Basic 971313.0000 shares 1 us-gaap/2024
0001213900-25-045828 20241231 Additional Paid In Capital 45213498.0000 USD 0 us-gaap/2024
0001213900-25-045828 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-045828 20240331 Alternative Cashless Exercise Of Common Stock Warrants 57589.0000 USD 1 0001213900-25-045828 Class Of Stock= Common Class C; Equity Components= Additional Paid In Capital;
0001213900-25-045828 20231231 Assets Current 12147525.0000 USD 0 us-gaap/2024
0001213900-25-045828 20250331 Common Stock Value 964.0000 USD 0 us-gaap/2024
0001213900-25-045828 20250331 Disposal Of Lab Supplies 6721.0000 USD 1 0001213900-25-045828
0001213900-25-045828 20240331 Fair Value Adjustment Of Warrants 68427.0000 USD 1 us-gaap/2024 Equity Components= Class C Common Stock Warrant;
0001213900-25-045828 20241231 Fair Value Adjustment Of Warrants 100000.0000 USD 4 us-gaap/2024 Equity Components= Class C Common Stock Warrant;
0001213900-25-045828 20250331 Fair Value Adjustment Of Warrants -1417.0000 USD 1 us-gaap/2024
0001213900-25-045828 20241231 Increase Decrease In Accounts Payable -576277.0000 USD 4 us-gaap/2024
0001213900-25-045828 20250331 Increase Decrease In Accounts Payable -158563.0000 USD 1 us-gaap/2024
0001213900-25-045828 20241231 Increase Decrease In Deferred Offering Costs -71133.0000 USD 4 0001213900-25-045828
0001213900-25-045828 20240331 Issuance Of Class D Common Stock Warrants In Connection With The February2024 Public Offering 6269684.0000 USD 1 0001213900-25-045828 Equity Components= Class D Common Stock Warrants; Subsidiary Sale Of Stock= February2024 Public Offering;
0001213900-25-045828 20231231 Liabilities And Stockholders Equity 12212609.0000 USD 0 us-gaap/2024
0001213900-25-045828 20240331 Net Cash Provided By Used In Operating Activities -2837969.0000 USD 1 us-gaap/2024
0001213900-25-045828 20241231 Net Income Loss -15038536.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-045828 20250331 Net Income Loss USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-045828 20231231 Noncash Fair Value Of Common Stock Warrants USD 4 0001213900-25-045828 Equity Components= Class G Common Stock Warrants;
0001213900-25-045828 20240331 Nonoperating Income Expense -779295.0000 USD 1 us-gaap/2024
0001213900-25-045828 20240331 Operating Expenses 1902138.0000 USD 1 us-gaap/2024
0001213900-25-045828 20240331 Operating Income Loss -1902138.0000 USD 1 us-gaap/2024
0001213900-25-045828 20241231 Other Nonoperating Income Expense -7144868.0000 USD 4 us-gaap/2024
0001213900-25-045828 20250331 Other Nonoperating Income Expense 42485.0000 USD 1 us-gaap/2024
0001213900-25-045828 20231231 Payments For Repurchase Of Redeemable Preferred Stock 5000.0000 USD 4 us-gaap/2024
0001213900-25-045828 20231231 Shares Outstanding shares 0 us-gaap/2024 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock; Restatement= Scenario Previously Reported;
0001213900-25-045828 20231231 Shares Outstanding 16484.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045828 20231231 Shares Outstanding 264537.0000 shares 0 us-gaap/2024 Equity Components= Common Stock; Restatement= Scenario Previously Reported;
0001213900-25-045828 20221231 Stockholders Equity USD 0 us-gaap/2024 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock; Restatement= Scenario Previously Reported;
0001213900-25-045828 20221231 Stockholders Equity 26399224.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital; Restatement= Scenario Previously Reported;
0001213900-25-045828 20221231 Stockholders Equity -25346848.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-045828 20231231 Stockholders Equity 16.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045828 20240331 Stockholders Equity 9473145.0000 USD 0 us-gaap/2024
0001213900-25-045828 20241231 Stockholders Equity 522.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045828 20231231 Stock Issued During Period Shares Restricted Stock Award Gross shares 4 us-gaap/2024 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-045828 20240331 Stock Issued During Period Value New Issues 5417045.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-045828 20241231 Stock Issued During Period Value New Issues USD 4 us-gaap/2024 Class Of Stock= February2024 Public Offering; Equity Components= Retained Earnings;
0001213900-25-045828 20231231 Stock Issued During Period Value Restricted Stock Award Gross USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-045828 20231231 Stock Issued During Period Value Retrospective Application Of Reverse Recapitalization 72.0000 USD 4 0001213900-25-045828 Equity Components= Additional Paid In Capital; Restatement= Scenario Previously Reported;
0001213900-25-045828 20240531 Stock Issued During Period Shares Issued For Services 653.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045828 20231231 Stock Issued During Period Shares New Issues 6450000.0000 shares 4 us-gaap/2024 Equity Components= Class C Common Stock Warrant;
0001213900-25-045828 20240831 Stock Issued During Period Shares New Issues 2548060.0000 shares 0 us-gaap/2024 Equity Components= Class D Common Stock Existing Warrants Issued;
0001213900-25-045828 20240831 Stock Issued During Period Shares New Issues 5096120.0000 shares 0 us-gaap/2024 Equity Components= Class E Common Stock Warrants;
0001213900-25-045828 20241231 Stock Issued During Period Shares New Issues 6217640.0000 shares 3 us-gaap/2024 Equity Components= Class C Common Stock Warrant;
0001213900-25-045828 20241231 Stock Issued During Period Shares New Issues shares 4 us-gaap/2024 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-045828 20241231 Warrant Inducement Exercises 3687918.0000 USD 4 0001213900-25-045828 Class Of Stock= Class E Common Stock Warrants;
0001213900-25-045828 20241231 Warrant Inducement Exercises 3501117.0000 USD 4 0001213900-25-045828 Class Of Stock= Common Class D; Equity Components= Additional Paid In Capital;
0001213900-25-045828 20241231 Warrant Inducement Exercises USD 4 0001213900-25-045828 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-045828 20231231 Weighted Average Number Of Diluted Shares Outstanding 14246.0000 shares 4 us-gaap/2024
0001213900-25-047104 20240331 Alternative Cashless Exercise Of Class F Common Stock Warrants USD 1 0001213900-25-047104 Equity Components= Class F Common Stock Warrants;
0001213900-25-047104 20250331 Alternative Cashless Exercise Of Class F Common Stock Warrants 3094680.0000 USD 1 0001213900-25-047104 Equity Components= Class F Common Stock Warrants;
0001213900-25-047104 20241231 Alternative Cashless Exercise Of Common Stock Warrants 57589.0000 USD 4 0001213900-25-047104
0001213900-25-047104 20241231 Alternative Cashless Exercise Of Common Stock Warrants 57589.0000 USD 4 0001213900-25-047104 Equity Components= Additional Paid In Capital;
0001213900-25-047104 20250331 Alternative Cashless Exercise Of Common Stock Warrants 383.0000 USD 1 0001213900-25-047104 Class Of Stock= Class F Common Stock Warrants; Equity Components= Common Stock;
0001213900-25-047104 20231231 Alternative Cashless Exercise Of Common Stock Warrants Shares shares 4 0001213900-25-047104 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-047104 20240331 Alternative Cashless Exercise Of Common Stock Warrants Shares 212.0000 shares 1 0001213900-25-047104 Class Of Stock= Common Class C; Equity Components= Common Stock;
0001213900-25-047104 20241231 Alternative Cashless Exercise Of Common Stock Warrants Shares shares 4 0001213900-25-047104 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-047104 20241231 Alternative Cashless Exercise Of Common Stock Warrants Shares 212.0000 shares 4 0001213900-25-047104 Equity Components= Common Stock;
0001213900-25-047104 20221231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 5252979.0000 USD 0 us-gaap/2024
0001213900-25-047104 20230131 Common Stock Shares Authorized 500000000.0000 shares 0 us-gaap/2024 Range= Maximum;
0001213900-25-047104 20250331 Common Stock Shares Authorized 500000000.0000 shares 0 us-gaap/2024 Range= Maximum;
0001213900-25-047104 20231231 Common Stock Shares Outstanding 16484.0000 shares 0 us-gaap/2024
0001213900-25-047104 20231231 Common Stock Value 16.0000 USD 0 us-gaap/2024
0001213900-25-047104 20241231 Common Stock Value 522.0000 USD 0 us-gaap/2024
0001213900-25-047104 20241231 Common Stock Warrants Exercises 241384.0000 USD 4 0001213900-25-047104 Class Of Stock= Common Class D; Equity Components= Additional Paid In Capital;
0001213900-25-047104 20241231 Common Stock Warrants Exercises Shares 6312.0000 shares 4 0001213900-25-047104 Class Of Stock= Common Class D; Equity Components= Common Stock;
0001213900-25-047104 20240331 Earnings Per Share Basic -39.3700 USD 1 us-gaap/2024
0001213900-25-047104 20241231 Earnings Per Share Basic -87.6800 USD 4 us-gaap/2024
0001213900-25-047104 20241231 Increase Decrease In Accrued Liabilities -2935920.0000 USD 4 us-gaap/2024
0001213900-25-047104 20231231 Increase Decrease In Deferred Offering Costs -82071.0000 USD 4 0001213900-25-047104
0001213900-25-047104 20231231 Issuance Of Stock And Warrants For Services Or Claims USD 4 us-gaap/2024
0001213900-25-047104 20250331 Property Plant And Equipment Net 42390.0000 USD 0 us-gaap/2024
0001213900-25-047104 20231231 Share Based Compensation 155721.0000 USD 4 us-gaap/2024
0001213900-25-047104 20240331 Share Based Compensation 32094.0000 USD 1 us-gaap/2024
0001213900-25-047104 20250331 Liabilities 1089519.0000 USD 0 us-gaap/2024
0001213900-25-047104 20240331 Net Cash Provided By Used In Investing Activities -19172.0000 USD 1 us-gaap/2024
0001213900-25-047104 20250331 Net Cash Provided By Used In Investing Activities USD 1 us-gaap/2024
0001213900-25-047104 20241231 Net Cash Provided By Used In Operating Activities -18321276.0000 USD 4 us-gaap/2024
0001213900-25-047104 20250331 Net Cash Provided By Used In Operating Activities -2794407.0000 USD 1 us-gaap/2024
0001213900-25-047104 20231231 Net Income Loss -120254.0000 USD 4 us-gaap/2024
0001213900-25-047104 20231231 Net Income Loss USD 4 us-gaap/2024 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-047104 20231231 Net Income Loss USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-047104 20241231 Net Income Loss -15038536.0000 USD 4 us-gaap/2024
0001213900-25-047104 20241231 Net Income Loss USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-047104 20240331 Payments To Acquire Property Plant And Equipment 19172.0000 USD 1 us-gaap/2024
0001213900-25-047104 20231231 Pre Funded Warrants Exercise 1.0000 USD 4 0001213900-25-047104 Equity Components= Common Stock;
0001213900-25-047104 20240331 Pre Funded Warrants Exercise 127.0000 USD 1 0001213900-25-047104 Class Of Stock= Common Class D;
0001213900-25-047104 20231231 Pre Funded Warrants Exercise Shares 699.0000 shares 4 0001213900-25-047104 Equity Components= Common Stock;
0001213900-25-047104 20241231 Proceeds From Warrant Exercises 241390.0000 USD 4 us-gaap/2024 Equity Components= Class D Common Stock Warrants;
0001213900-25-047104 20241231 Share Based Compensation 168850.0000 USD 4 us-gaap/2024
0001213900-25-047104 20231231 Stockholders Equity 32114801.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-047104 20231231 Stockholders Equity 32114552.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital; Restatement= Scenario Previously Reported;
0001213900-25-047104 20241231 Stock Issued During Period Shares Issued For Services shares 4 us-gaap/2024 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-047104 20240131 Stock Issued During Period Shares New Issues 8029.0000 shares 0 us-gaap/2024 Equity Components= Class D Pre Funded Warrants;
0001213900-25-047104 20240331 Stock Issued During Period Shares New Issues 8029.0000 shares 1 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-047104 20241231 Stock Issued During Period Value Issued For Services USD 4 us-gaap/2024 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-047104 20240331 Stock Issued During Period Value New Issues 5417053.0000 USD 1 us-gaap/2024
0001213900-25-047104 20241231 Stock Issued During Period Value New Issues 8.0000 USD 4 us-gaap/2024 Class Of Stock= February2024 Public Offering; Equity Components= Common Stock;
0001213900-25-047104 20250331 Stock Issued During Period Value Other USD 1 us-gaap/2024
0001213900-25-047104 20231231 Stock Issued During Period Value Restricted Stock Award Gross USD 4 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-047104 20231231 Stock Redeemed Or Called During Period Shares shares 4 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-047104 20241231 Warrant Inducement Exercises Shares 159249.0000 shares 4 0001213900-25-047104 Class Of Stock= Common Class D; Equity Components= Common Stock;
0001213900-25-047104 20241231 Warrant Inducement Exercises Shares shares 4 0001213900-25-047104 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-047104 20231231 Weighted Average Number Of Shares Outstanding Basic 14246.0000 shares 4 us-gaap/2024
0001213900-25-045828 20241231 Depreciation 27923.0000 USD 4 us-gaap/2024
0001213900-25-045828 20250331 Earnings Per Share Basic -2.1100 USD 1 us-gaap/2024
0001213900-25-045828 20231231 Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock USD 4 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045828 20231231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 155721.0000 USD 4 us-gaap/2024
0001213900-25-045828 20231231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 155721.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-045828 20231231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-045828 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 32094.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-045828 20241231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 4 us-gaap/2024 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-045828 20231231 Alternative Cashless Exercise Of Common Stock Warrants USD 4 0001213900-25-045828 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-045828 20240331 Alternative Cashless Exercise Of Common Stock Warrants Shares 212.0000 shares 1 0001213900-25-045828 Class Of Stock= Common Class C; Equity Components= Common Stock;
0001213900-25-045828 20241231 Alternative Cashless Exercise Of Common Stock Warrants Shares shares 4 0001213900-25-045828 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-045828 20250331 Alternative Cashless Exercise Of Common Stock Warrants Shares 62500.0000 shares 1 0001213900-25-045828
0001213900-25-045828 20250331 Assets 3970271.0000 USD 0 us-gaap/2024
0001213900-25-045828 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 14551740.0000 USD 0 us-gaap/2024
0001213900-25-045828 20241231 Commitments And Contingencies USD 0 us-gaap/2024
0001213900-25-045828 20231231 Common Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2024
0001213900-25-045828 20250331 Common Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2024
0001213900-25-045828 20230131 Common Stock Shares Authorized 500000000.0000 shares 0 us-gaap/2024 Range= Maximum;
0001213900-25-045828 20231231 Common Stock Shares Authorized 500000000.0000 shares 0 us-gaap/2024
0001213900-25-045828 20250331 Common Stock Shares Authorized 500000000.0000 shares 0 us-gaap/2024 Range= Maximum;
0001213900-25-045828 20231231 Common Stock Shares Issued 16484.0000 shares 0 us-gaap/2024
0001213900-25-045828 20231231 Common Stock Value 16.0000 USD 0 us-gaap/2024
0001213900-25-045828 20241231 Common Stock Warrants Exercises USD 4 0001213900-25-045828 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-045828 20231231 Deferred Offering Costs Included In Accounts Payable And Accrued Expenses 66033.0000 USD 4 0001213900-25-045828
0001213900-25-045828 20241231 Fair Value Adjustment Of Warrants -81441.0000 USD 4 us-gaap/2024
0001213900-25-045828 20240331 General And Administrative Expense 1184556.0000 USD 1 us-gaap/2024
0001213900-25-045828 20240331 Increase Decrease In Accounts Payable 321767.0000 USD 1 us-gaap/2024
0001213900-25-045828 20231231 Increase Decrease In Accrued Liabilities 161963.0000 USD 4 us-gaap/2024
0001213900-25-045828 20240331 Increase Decrease In Accrued Liabilities -532180.0000 USD 1 us-gaap/2024
0001213900-25-045828 20231231 Increase Decrease In Deferred Offering Costs -82071.0000 USD 4 0001213900-25-045828
0001213900-25-045828 20250331 Increase Decrease In Deferred Offering Costs USD 1 0001213900-25-045828
0001213900-25-045828 20231231 Increase Decrease In Prepaid Deferred Expense And Other Assets 11559.0000 USD 4 us-gaap/2024
0001213900-25-045828 20240331 Increase Decrease In Prepaid Deferred Expense And Other Assets -12815.0000 USD 1 us-gaap/2024
0001213900-25-045828 20231231 Liabilities 5564894.0000 USD 0 us-gaap/2024
0001213900-25-045828 20231231 Net Cash Provided By Used In Investing Activities USD 4 us-gaap/2024
0001213900-25-045828 20241231 Net Cash Provided By Used In Investing Activities -19171.0000 USD 4 us-gaap/2024
0001213900-25-045828 20250331 Net Cash Provided By Used In Investing Activities USD 1 us-gaap/2024
0001213900-25-045828 20231231 Net Cash Provided By Used In Operating Activities -7286286.0000 USD 4 us-gaap/2024
0001213900-25-045828 20241231 Net Income Loss USD 4 us-gaap/2024 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-045828 20241231 Noncash Fair Value Of Common Stock Warrants 4104680.0000 USD 4 0001213900-25-045828 Equity Components= Class F Common Stock Warrants;
0001213900-25-045828 20241231 Operating Income Loss -7975109.0000 USD 4 us-gaap/2024
0001213900-25-045828 20241231 Payments To Acquire Property Plant And Equipment 19171.0000 USD 4 us-gaap/2024
0001213900-25-045828 20240331 Pre Funded Warrants Exercise USD 1 0001213900-25-045828 Class Of Stock= Common Class D; Equity Components= Retained Earnings;
0001213900-25-045828 20231231 Pre Funded Warrants Exercise Shares shares 4 0001213900-25-045828 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-045828 20241231 Prepaid Expense And Other Assets Current 66699.0000 USD 0 us-gaap/2024
0001213900-25-045828 20231231 Proceeds From Warrant Exercises 34.0000 USD 4 us-gaap/2024 Equity Components= Class C Pre Funded Warrants;
0001213900-25-045828 20241231 Retained Earnings Accumulated Deficit -40505638.0000 USD 0 us-gaap/2024
0001213900-25-045828 20241231 Share Based Compensation 168850.0000 USD 4 us-gaap/2024
0001213900-25-045828 20241231 Shares Outstanding 522223.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045828 20231231 Stock Issued During Period Shares New Issues 6017.0000 shares 4 us-gaap/2024 Class Of Stock= February2023 Public Offering; Equity Components= Common Stock;
0001213900-25-045828 20250331 Stock Issued During Period Shares Other 58568.0000 shares 1 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045828 20231231 Stock Issued During Period Shares Retrospective Application Of Reverse Recapitalization shares 4 0001213900-25-045828 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock; Restatement= Scenario Previously Reported;
0001213900-25-045828 20241231 Stock Issued During Period Value Issued For Services 24999.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-045828 20231231 Stock Issued During Period Value New Issues 33469.0000 USD 4 us-gaap/2024 Class Of Stock= February2023 Public Offering; Equity Components= Additional Paid In Capital;
0001213900-25-045828 20241231 Stock Issued During Period Value New Issues 5417045.0000 USD 4 us-gaap/2024 Class Of Stock= February2024 Public Offering; Equity Components= Additional Paid In Capital;
0001213900-25-045828 20241231 Stock Issued During Period Value Retrospective Application Of Reverse Recapitalization -249.0000 USD 4 0001213900-25-045828 Equity Components= Common Stock; Restatement= Scenario Previously Reported;
0001213900-25-045828 20231231 Stock Redeemed Or Called During Period Shares -1.0000 shares 4 us-gaap/2024 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-045828 20241231 Warrant Inducement Exercises 3501276.0000 USD 4 0001213900-25-045828 Class Of Stock= Common Class D;
0001213900-25-045828 20241231 Warrant Liability 2246.0000 USD 0 0001213900-25-045828
0001213900-25-045828 20250331 Weighted Average Number Of Shares Outstanding Basic 125000.0000 shares 1 us-gaap/2024 Equity Components= Class F Common Stock Warrants;
0001213900-25-047104 20241231 Accounts Payable Current 783621.0000 USD 0 us-gaap/2024
0001213900-25-047104 20231231 Accrued Liabilities Current 1152460.0000 USD 0 us-gaap/2024
0001213900-25-047104 20231231 Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock USD 4 us-gaap/2024
0001213900-25-047104 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 1 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-047104 20231231 Alternative Cashless Exercise Of Common Stock Warrants USD 4 0001213900-25-047104 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-047104 20231231 Alternative Cashless Exercise Of Common Stock Warrants 5.0000 USD 4 0001213900-25-047104 Equity Components= Common Stock;
0001213900-25-047104 20250331 Alternative Cashless Exercise Of Common Stock Warrants Shares 62500.0000 shares 1 0001213900-25-047104
0001213900-25-047104 20241231 Common Stock Warrants Exercises USD 4 0001213900-25-047104 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-047104 20241231 Earnings Per Share Diluted -87.6800 USD 4 us-gaap/2024
0001213900-25-047104 20231231 Fair Value Adjustment Of Warrants -8328937.0000 USD 4 us-gaap/2024
0001213900-25-047104 20240331 Fair Value Adjustment Of Warrants -68427.0000 USD 1 us-gaap/2024
0001213900-25-047104 20241231 Increase Decrease In Accounts Payable -576277.0000 USD 4 us-gaap/2024
0001213900-25-047104 20250331 Increase Decrease In Deferred Offering Costs USD 1 0001213900-25-047104
0001213900-25-047104 20250331 Increase Decrease In Prepaid Deferred Expense And Other Assets 156571.0000 USD 1 us-gaap/2024
0001213900-25-047104 20241231 Issuance Of Stock And Warrants For Services Or Claims 25000.0000 USD 4 us-gaap/2024
0001213900-25-047104 20250331 Net Income Loss -2051085.0000 USD 1 us-gaap/2024
0001213900-25-047104 20241231 Noncash Equity Issuance Costs In Connection With Warrant Inducement Included In Accounts Payable 25968.0000 USD 4 0001213900-25-047104
0001213900-25-047104 20241231 Noncash Fair Value Of Common Stock Warrants 4104680.0000 USD 4 0001213900-25-047104 Equity Components= Class F Common Stock Warrants;
0001213900-25-047104 20241231 Noncash Fair Value Of Common Stock Warrants With Warrant Inducement 939679.0000 USD 4 0001213900-25-047104 Equity Components= Class D Common Stock Warrants;
0001213900-25-047104 20241231 Noncash Fair Value Of New Common Stock Warrants With Public Offering USD 4 0001213900-25-047104 Equity Components= Class C Common Stock Warrant; Subsidiary Sale Of Stock= February2023 Public Offering;
0001213900-25-047104 20240331 Nonoperating Income Expense -779295.0000 USD 1 us-gaap/2024
0001213900-25-047104 20241231 Nonoperating Income Expense -7063427.0000 USD 4 us-gaap/2024
0001213900-25-047104 20250331 Nonoperating Income Expense 43902.0000 USD 1 us-gaap/2024
0001213900-25-047104 20240331 Operating Expenses 1902138.0000 USD 1 us-gaap/2024
0001213900-25-047104 20231231 Pre Funded Warrants Exercise Shares shares 4 0001213900-25-047104 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-047104 20231231 Prepaid Expense And Other Assets Current 84691.0000 USD 0 us-gaap/2024
0001213900-25-047104 20230131 Proceeds From Issuance Initial Public Offering 14000000.0000 USD 0 us-gaap/2024
0001213900-25-047104 20241231 Proceeds From Warrant Exercises 3501276.0000 USD 4 us-gaap/2024 Equity Components= Warrant Inducement;
0001213900-25-047104 20231231 Property Plant And Equipment Net 65084.0000 USD 0 us-gaap/2024
0001213900-25-047104 20221231 Shares Outstanding 1.0000 shares 0 us-gaap/2024 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-047104 20231231 Shares Outstanding 16484.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-047104 20240331 Stockholders Equity 102.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-047104 20240331 Stockholders Equity -28148535.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-047104 20241231 Stockholders Equity 4708382.0000 USD 0 us-gaap/2024
0001213900-25-047104 20241231 Stockholders Equity 45213498.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-047104 20231231 Stock Issued During Period Shares New Issues 6450000.0000 shares 4 us-gaap/2024 Equity Components= Class C Common Stock Warrant;
0001213900-25-047104 20231231 Stock Issued During Period Shares Retrospective Application Of Reverse Recapitalization shares 4 0001213900-25-047104 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock; Restatement= Scenario Previously Reported;
0001213900-25-047104 20241231 Stock Issued During Period Value Issued For Services 25000.0000 USD 4 us-gaap/2024
0001213900-25-047104 20241231 Stock Issued During Period Value Issued For Services 1.0000 USD 4 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-047104 20231231 Stock Issued During Period Value New Issues 33474.0000 USD 4 us-gaap/2024 Class Of Stock= February2023 Public Offering;
0001213900-25-047104 20241231 Stock Issued During Period Value New Issues 5417053.0000 USD 4 us-gaap/2024 Class Of Stock= February2024 Public Offering;
0001213900-25-047104 20241231 Stock Issued During Period Value New Issues USD 4 us-gaap/2024 Class Of Stock= February2024 Public Offering; Equity Components= Retained Earnings;
0001213900-25-047104 20241231 Stock Issued During Period Value New Issues USD 4 us-gaap/2024 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-047104 20231231 Stock Issued During Period Value Restricted Stock Award Gross USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-047104 20231231 Stock Issued During Period Value Retrospective Application Of Reverse Recapitalization -72.0000 USD 4 0001213900-25-047104 Equity Components= Common Stock; Restatement= Scenario Previously Reported;
0001213900-25-047104 20241231 Stock Issued During Period Value Retrospective Application Of Reverse Recapitalization -249.0000 USD 4 0001213900-25-047104 Equity Components= Common Stock; Restatement= Scenario Previously Reported;
0001213900-25-047104 20241231 Warrant Inducement Exercises 3687664.0000 USD 4 0001213900-25-047104 Class Of Stock= Class E Common Stock Warrants; Equity Components= Additional Paid In Capital;
0001213900-25-047104 20241231 Weighted Average Number Of Shares Outstanding Basic 171510.0000 shares 4 us-gaap/2024
0001213900-25-045828 20231231 Additional Paid In Capital 32114801.0000 USD 0 us-gaap/2024
0001213900-25-045828 20231231 Accounts Payable Current 1359898.0000 USD 0 us-gaap/2024
0001213900-25-045828 20250331 Accounts Payable Current 625058.0000 USD 0 us-gaap/2024
0001213900-25-045828 20250331 Accrued Liabilities Current 463632.0000 USD 0 us-gaap/2024
0001213900-25-045828 20231231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 4 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045828 20241231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 168850.0000 USD 4 us-gaap/2024
0001213900-25-045828 20241231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 168850.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-045828 20241231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-045828 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 1 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045828 20231231 Alternative Cashless Exercise Of Common Stock Warrants 5526287.0000 USD 4 0001213900-25-045828
0001213900-25-045828 20240331 Alternative Cashless Exercise Of Common Stock Warrants USD 1 0001213900-25-045828 Class Of Stock= Common Class C; Equity Components= Retained Earnings;
0001213900-25-045828 20250331 Alternative Cashless Exercise Of Common Stock Warrants Shares 383005.0000 shares 1 0001213900-25-045828 Class Of Stock= Class F Common Stock Warrants; Equity Components= Common Stock;
0001213900-25-045828 20241231 Assets Current 6565717.0000 USD 0 us-gaap/2024
0001213900-25-045828 20250331 Assets Current 3927881.0000 USD 0 us-gaap/2024
0001213900-25-045828 20231231 Cash And Cash Equivalents At Carrying Value 11991701.0000 USD 0 us-gaap/2024
0001213900-25-045828 20230131 Common Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045828 20241231 Common Stock Shares Authorized 500000000.0000 shares 0 us-gaap/2024
0001213900-25-045828 20241231 Common Stock Warrants Exercises 241384.0000 USD 4 0001213900-25-045828 Class Of Stock= Common Class D; Equity Components= Additional Paid In Capital;
0001213900-25-045828 20241231 Deferred Offering Costs USD 0 us-gaap/2024
0001213900-25-045828 20231231 Earnings Per Share Basic -8.4400 USD 4 us-gaap/2024
0001213900-25-045828 20240331 Fair Value Adjustment Of Warrants -68427.0000 USD 1 us-gaap/2024
0001213900-25-045828 20250331 General And Administrative Expense 1236157.0000 USD 1 us-gaap/2024
0001213900-25-045828 20240331 Increase Decrease In Deferred Offering Costs -71133.0000 USD 1 0001213900-25-045828
0001213900-25-045828 20241231 Liabilities 1913667.0000 USD 0 us-gaap/2024
0001213900-25-045828 20231231 Liabilities Current 5564894.0000 USD 0 us-gaap/2024
0001213900-25-045828 20241231 Net Cash Provided By Used In Financing Activities 12847764.0000 USD 4 us-gaap/2024
0001213900-25-045828 20231231 Net Income Loss USD 4 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045828 20240331 Net Income Loss -2681433.0000 USD 1 us-gaap/2024
0001213900-25-045828 20250331 Net Income Loss -2051085.0000 USD 1 us-gaap/2024
0001213900-25-045828 20231231 Noncash Fair Value Of Common Stock Warrants With Warrant Inducement USD 4 0001213900-25-045828 Equity Components= Class D Common Stock Warrants;
0001213900-25-045828 20250331 Nonoperating Income Expense 43902.0000 USD 1 us-gaap/2024
0001213900-25-045828 20250331 Operating Expenses 2094987.0000 USD 1 us-gaap/2024
0001213900-25-045828 20250331 Operating Income Loss -2094987.0000 USD 1 us-gaap/2024
0001213900-25-045828 20231231 Pre Funded Warrants Exercise Shares 699.0000 shares 4 0001213900-25-045828 Equity Components= Common Stock;
0001213900-25-045828 20231231 Prepaid Expense And Other Assets Current 84691.0000 USD 0 us-gaap/2024
0001213900-25-045828 20240331 Proceeds From Warrant Exercises 127.0000 USD 1 us-gaap/2024 Equity Components= Class D Pre Funded Warrants;
0001213900-25-045828 20241231 Proceeds From Warrant Exercises USD 4 us-gaap/2024 Equity Components= Class C Pre Funded Warrants;
0001213900-25-045828 20241231 Property Plant And Equipment Net 56332.0000 USD 0 us-gaap/2024
0001213900-25-045828 20221231 Shares Outstanding 1.0000 shares 0 us-gaap/2024 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock; Restatement= Scenario Previously Reported;
0001213900-25-045828 20221231 Shares Outstanding 4812.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045828 20221231 Stockholders Equity 1052453.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001213900-25-045828 20231231 Stockholders Equity 265.0000 USD 0 us-gaap/2024 Equity Components= Common Stock; Restatement= Scenario Previously Reported;
0001213900-25-045828 20240331 Stockholders Equity 102.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045828 20250331 Stockholders Equity -42556723.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-045828 20240531 Stock Issued During Period Shares Issued For Services 653.0000 shares 0 us-gaap/2024 Equity Components= Class D Common Stock Warrants;
0001213900-25-045828 20230131 Stock Issued During Period Shares New Issues 6017.0000 shares 0 us-gaap/2024
0001213900-25-045828 20230131 Stock Issued During Period Shares New Issues 699.0000 shares 0 us-gaap/2024 Equity Components= Class C Pre Funded Warrants;
0001213900-25-045828 20240131 Stock Issued During Period Shares New Issues 2730000.0000 shares 0 us-gaap/2024 Equity Components= Class D Common Stock Warrant;
0001213900-25-045828 20241130 Stock Issued During Period Shares New Issues 6096060.0000 shares 0 us-gaap/2024 Equity Components= Class G Common Stock Warrants;
0001213900-25-045828 20250228 Stock Issued During Period Shares New Issues 3064040.0000 shares 0 us-gaap/2024 Equity Components= Class F Common Stock Warrants; Subsequent Event Type= Subsequent Event;
0001213900-25-045828 20241231 Stock Issued During Period Value Issued For Services 25000.0000 USD 4 us-gaap/2024
0001213900-25-045828 20231231 Stock Issued During Period Value New Issues 5.0000 USD 4 us-gaap/2024 Class Of Stock= February2023 Public Offering; Equity Components= Common Stock;
0001213900-25-045828 20240331 Stock Issued During Period Value New Issues USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-045828 20250331 Stock Issued During Period Value Other USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-045828 20231231 Stock Issued During Period Value Restricted Stock Award Gross USD 4 us-gaap/2024 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-045828 20241231 Stock Issued During Period Value Retrospective Application Of Reverse Recapitalization 249.0000 USD 4 0001213900-25-045828 Equity Components= Additional Paid In Capital; Restatement= Scenario Previously Reported;
0001213900-25-045828 20241231 Warrant Inducement Exercises 254.0000 USD 4 0001213900-25-045828 Class Of Stock= Class E Common Stock Warrants; Equity Components= Common Stock;
0001213900-25-045828 20241231 Warrant Inducement Exercises 159.0000 USD 4 0001213900-25-045828 Class Of Stock= Common Class D; Equity Components= Common Stock;
0001213900-25-045828 20241231 Warrant Inducement Exercises USD 4 0001213900-25-045828 Class Of Stock= Common Class D; Equity Components= Retained Earnings;
0001213900-25-045828 20241231 Warrant Inducement Exercises Shares 254002.0000 shares 4 0001213900-25-045828 Class Of Stock= Class E Common Stock Warrants; Equity Components= Common Stock;
0001213900-25-045828 20250331 Warrant Liability 829.0000 USD 0 0001213900-25-045828
0001213900-25-047104 20241231 Accrued Liabilities Current 1127800.0000 USD 0 us-gaap/2024
0001213900-25-047104 20231231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 155721.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-047104 20231231 Alternative Cashless Exercise Of Common Stock Warrants 5526282.0000 USD 4 0001213900-25-047104 Equity Components= Additional Paid In Capital;
0001213900-25-047104 20240331 Alternative Cashless Exercise Of Common Stock Warrants USD 1 0001213900-25-047104 Class Of Stock= Common Class C; Equity Components= Common Stock;
0001213900-25-047104 20241231 Alternative Cashless Exercise Of Common Stock Warrants USD 4 0001213900-25-047104 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-047104 20231231 Alternative Cashless Exercise Of Common Stock Warrants Shares 4948.0000 shares 4 0001213900-25-047104 Equity Components= Common Stock;
0001213900-25-047104 20250331 Alternative Cashless Of Common Stock Warrants Exercise USD 1 0001213900-25-047104 Equity Components= Class C Common Stock Warrant;
0001213900-25-047104 20241231 Cash And Cash Equivalents At Carrying Value 6499018.0000 USD 0 us-gaap/2024
0001213900-25-047104 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect 6738722.0000 USD 4 us-gaap/2024
0001213900-25-047104 20231231 Common Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2024
0001213900-25-047104 20250331 Common Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2024
0001213900-25-047104 20231231 Common Stock Shares Issued 16484.0000 shares 0 us-gaap/2024
0001213900-25-047104 20250331 Common Stock Shares Outstanding 963796.0000 shares 0 us-gaap/2024
0001213900-25-047104 20250331 Earnings Per Share Basic -2.1100 USD 1 us-gaap/2024
0001213900-25-047104 20231231 Earnings Per Share Diluted -8.4400 USD 4 us-gaap/2024
0001213900-25-047104 20250331 Fair Value Adjustment Of Warrants 1417.0000 USD 1 us-gaap/2024 Equity Components= Class C Common Stock Warrant;
0001213900-25-047104 20231231 General And Administrative Expense 4510762.0000 USD 4 us-gaap/2024
0001213900-25-047104 20240331 Increase Decrease In Prepaid Deferred Expense And Other Assets -12815.0000 USD 1 us-gaap/2024
0001213900-25-047104 20250331 Issuance Of Class D Common Stock Warrants In Connection With The February2024 Public Offering USD 1 0001213900-25-047104 Equity Components= Class D Common Stock Warrants; Subsidiary Sale Of Stock= February2024 Public Offering;
0001213900-25-047104 20240331 Net Cash Provided By Used In Financing Activities 5417180.0000 USD 1 us-gaap/2024
0001213900-25-047104 20250331 Net Cash Provided By Used In Financing Activities USD 1 us-gaap/2024
0001213900-25-047104 20231231 Net Cash Provided By Used In Investing Activities USD 4 us-gaap/2024
0001213900-25-047104 20240331 Net Income Loss USD 1 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-047104 20240331 Net Income Loss -2681433.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-047104 20241231 Net Income Loss USD 4 us-gaap/2024 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-047104 20241231 Operating Expenses 7975109.0000 USD 4 us-gaap/2024
0001213900-25-047104 20231231 Other Nonoperating Income Expense 207473.0000 USD 4 us-gaap/2024
0001213900-25-047104 20240331 Other Nonoperating Income Expense -847722.0000 USD 1 us-gaap/2024
0001213900-25-047104 20231231 Payments To Acquire Property Plant And Equipment USD 4 us-gaap/2024
0001213900-25-047104 20241231 Payments To Acquire Property Plant And Equipment 19171.0000 USD 4 us-gaap/2024
0001213900-25-047104 20250331 Payments To Acquire Property Plant And Equipment USD 1 us-gaap/2024
0001213900-25-047104 20231231 Pre Funded Warrants Exercise USD 4 0001213900-25-047104 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-047104 20231231 Pre Funded Warrants Exercise 33.0000 USD 4 0001213900-25-047104 Equity Components= Additional Paid In Capital;
0001213900-25-047104 20241231 Pre Funded Warrants Exercise 78.0000 USD 4 0001213900-25-047104 Equity Components= Common Stock;
0001213900-25-047104 20241231 Pre Funded Warrants Exercise Shares shares 4 0001213900-25-047104 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-047104 20241231 Prepaid Expense And Other Assets Current 66699.0000 USD 0 us-gaap/2024
0001213900-25-047104 20240131 Stock Issued During Period Shares New Issues 85311.0000 shares 0 us-gaap/2024
0001213900-25-047104 20250331 Prepaid Expense And Other Assets Current 223270.0000 USD 0 us-gaap/2024
0001213900-25-047104 20240131 Proceeds From Issuance Initial Public Offering 5400000.0000 USD 0 us-gaap/2024
0001213900-25-047104 20231231 Proceeds From Warrant Exercises USD 4 us-gaap/2024 Equity Components= Class D Common Stock Warrants;
0001213900-25-047104 20241231 Research And Development Expense 3548996.0000 USD 4 us-gaap/2024
0001213900-25-047104 20231231 Retained Earnings Accumulated Deficit -25467102.0000 USD 0 us-gaap/2024
0001213900-25-047104 20241231 Retained Earnings Accumulated Deficit -40505638.0000 USD 0 us-gaap/2024
0001213900-25-047104 20221231 Stockholders Equity 5.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-047104 20221231 Stockholders Equity 77.0000 USD 0 us-gaap/2024 Equity Components= Common Stock; Restatement= Scenario Previously Reported;
0001213900-25-047104 20231231 Stockholders Equity USD 0 us-gaap/2024 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock; Restatement= Scenario Previously Reported;
0001213900-25-047104 20241130 Stock Issued During Period Shares New Issues 4064040.0000 shares 0 us-gaap/2024 Equity Components= Class F Common Stock Warrants;
0001213900-25-047104 20241231 Stock Issued During Period Shares New Issues 5160.0000 shares 3 us-gaap/2024 Equity Components= Class C Common Stock Warrant; Subsidiary Sale Of Stock= Two Thousand Twenty Three Public Offering;
0001213900-25-047104 20241231 Stock Issued During Period Shares New Issues 8029.0000 shares 4 us-gaap/2024 Class Of Stock= February2024 Public Offering; Equity Components= Common Stock;
0001213900-25-047104 20241231 Stock Issued During Period Shares Retrospective Application Of Reverse Recapitalization shares 4 0001213900-25-047104 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock; Restatement= Scenario Previously Reported;
0001213900-25-047104 20241231 Stock Issued During Period Shares Retrospective Application Of Reverse Recapitalization -248029.0000 shares 4 0001213900-25-047104 Equity Components= Common Stock; Restatement= Scenario Previously Reported;
0001213900-25-047104 20231231 Stock Issued During Period Value New Issues USD 4 us-gaap/2024 Class Of Stock= February2023 Public Offering; Equity Components= Retained Earnings;
0001213900-25-047104 20231231 Stock Issued During Period Value New Issues USD 4 us-gaap/2024 Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock;
0001213900-25-047104 20240331 Stock Issued During Period Value New Issues 8.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-047104 20250331 Stock Issued During Period Value Other 59.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045828 20241231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 4 us-gaap/2024 Equity Components= Common Stock;
0001213900-25-045828 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-045828 20231231 Alternative Cashless Exercise Of Common Stock Warrants 5526282.0000 USD 4 0001213900-25-045828 Equity Components= Additional Paid In Capital;
0001213900-25-045828 20231231 Alternative Cashless Exercise Of Common Stock Warrants 5.0000 USD 4 0001213900-25-045828 Equity Components= Common Stock;
0001213900-25-045828 20240331 Alternative Cashless Exercise Of Common Stock Warrants 57589.0000 USD 1 0001213900-25-045828 Class Of Stock= Common Class C;
0001213900-25-045828 20241231 Alternative Cashless Exercise Of Common Stock Warrants USD 4 0001213900-25-045828 Equity Components= Common Stock;
0001213900-25-045828 20250331 Alternative Cashless Exercise Of Common Stock Warrants -383.0000 USD 1 0001213900-25-045828 Class Of Stock= Class F Common Stock Warrants; Equity Components= Additional Paid In Capital;
0001213900-25-045828 20250331 Common Stock Shares Authorized 500000000.0000 shares 0 us-gaap/2024
0001213900-25-045828 20241231 Common Stock Warrants Exercises 241390.0000 USD 4 0001213900-25-045828 Class Of Stock= Common Class D;
0001213900-25-045828 20241231 Common Stock Warrants Exercises 6.0000 USD 4 0001213900-25-045828 Class Of Stock= Common Class D; Equity Components= Common Stock;
0001213900-25-045828 20250331 Earnings Per Share Diluted -2.1100 USD 1 us-gaap/2024
0001213900-25-045828 20241231 Increase Decrease In Prepaid Deferred Expense And Other Assets -17992.0000 USD 4 us-gaap/2024
0001213900-25-045828 20250331 Issuance Of Class D Common Stock Warrants In Connection With The February2024 Public Offering USD 1 0001213900-25-045828 Equity Components= Class D Common Stock Warrants; Subsidiary Sale Of Stock= February2024 Public Offering;
0001213900-25-045828 20240331 Net Cash Provided By Used In Investing Activities -19172.0000 USD 1 us-gaap/2024
0001213900-25-045828 20250331 Net Cash Provided By Used In Operating Activities -2794407.0000 USD 1 us-gaap/2024
0001213900-25-045828 20241231 Net Income Loss -15038536.0000 USD 4 us-gaap/2024
0001213900-25-045828 20231231 Noncash Equity Issuance Costs In Connection With Warrant Inducement Included In Accounts Payable USD 4 0001213900-25-045828
0001213900-25-045828 20241231 Noncash Fair Value Of Common Stock Warrants With Warrant Inducement 4887683.0000 USD 4 0001213900-25-045828 Equity Components= Class E Common Stock Warrants;
0001213900-25-045828 20231231 Noncash Fair Value Of New Common Stock Warrants With Public Offering USD 4 0001213900-25-045828 Equity Components= Class D Common Stock Warrants; Subsidiary Sale Of Stock= February2024 Public Offering;
0001213900-25-045828 20241231 Noncash Fair Value Of New Common Stock Warrants With Public Offering 6269684.0000 USD 4 0001213900-25-045828 Equity Components= Class D Common Stock Warrants; Subsidiary Sale Of Stock= February2024 Public Offering;
0001213900-25-045828 20231231 Operating Income Loss -8656664.0000 USD 4 us-gaap/2024
0001213900-25-045828 20240331 Other Nonoperating Income Expense -847722.0000 USD 1 us-gaap/2024
0001213900-25-045828 20231231 Payments To Acquire Property Plant And Equipment USD 4 us-gaap/2024
0001213900-25-045828 20231231 Pre Funded Warrants Exercise USD 4 0001213900-25-045828 Equity Components= Retained Earnings;
0001213900-25-045828 20240331 Pre Funded Warrants Exercise 49.0000 USD 1 0001213900-25-045828 Class Of Stock= Common Class D; Equity Components= Additional Paid In Capital;
0001213900-25-045828 20241231 Pre Funded Warrants Exercise USD 4 0001213900-25-045828 Equity Components= Retained Earnings;
0001213900-25-045828 20240331 Pre Funded Warrants Exercise Shares 77282.0000 shares 1 0001213900-25-045828 Class Of Stock= Common Class D; Equity Components= Common Stock;
0001213900-25-045828 20231231 Proceeds From Warrant Exercises USD 4 us-gaap/2024 Equity Components= Class E Common Stock Warrants;
0001213900-25-045828 20241231 Proceeds From Warrant Exercises 127.0000 USD 4 us-gaap/2024 Equity Components= Class D Pre Funded Warrants;
0001213900-25-045828 20231231 Research And Development Expense 4145902.0000 USD 4 us-gaap/2024
0001213900-25-045828 20240331 Research And Development Expense 717582.0000 USD 1 us-gaap/2024
0001213900-25-045828 20241231 Research And Development Expense 3548996.0000 USD 4 us-gaap/2024
0001213900-25-045828 20250331 Share Based Compensation 223455.0000 USD 1 us-gaap/2024
0001213900-25-045828 20221231 Shares Outstanding 77375.0000 shares 0 us-gaap/2024 Equity Components= Common Stock; Restatement= Scenario Previously Reported;
0001213900-25-045828 20231231 Stockholders Equity -25467102.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings; Restatement= Scenario Previously Reported;
0001213900-25-045828 20231231 Stockholders Equity 6647715.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001213900-25-045828 20241231 Stockholders Equity -40505638.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-045828 20250331 Stockholders Equity 45436511.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-045828 20250331 Stock Issued During Period Shares New Issues 191503.0000 shares 1 us-gaap/2024 Equity Components= Class F Common Stock Warrants;
0001213900-25-045828 20241231 Stock Issued During Period Shares Reverse Stock Split Fractional Stock Round Up -24.0000 shares 4 0001213900-25-045828 Equity Components= Common Stock; Restatement= Scenario Previously Reported;
0001213900-25-045828 20250331 Stock Issued During Period Value Other USD 1 us-gaap/2024
0001213900-25-045828 20250331 Stock Issued During Period Value Other -59.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001213900-25-045828 20231231 Stock Issued During Period Value Retrospective Application Of Reverse Recapitalization USD 4 0001213900-25-045828 Equity Components= Retained Earnings; Restatement= Scenario Previously Reported;
0001213900-25-045828 20241231 Stock Issued During Period Value Retrospective Application Of Reverse Recapitalization USD 4 0001213900-25-045828 Equity Components= Retained Earnings; Restatement= Scenario Previously Reported;
0001213900-25-045828 20241231 Warrant Inducement Exercises 3687664.0000 USD 4 0001213900-25-045828 Class Of Stock= Class E Common Stock Warrants; Equity Components= Additional Paid In Capital;
0001213900-25-045828 20241231 Warrant Inducement Exercises USD 4 0001213900-25-045828 Class Of Stock= Class E Common Stock Warrants; Equity Components= Retained Earnings;
0001213900-25-045828 20231231 Warrant Liability 141276.0000 USD 0 0001213900-25-045828
0001213900-25-045828 20231231 Weighted Average Number Of Shares Outstanding Basic 14246.0000 shares 4 us-gaap/2024
0001213900-25-045828 20250331 Weighted Average Number Of Shares Outstanding Basic 3.0000 shares 1 us-gaap/2024 Award Type= Rollover Restricted Stock Unit Awards;
0001213900-25-047104 20250331 Additional Paid In Capital 45436511.0000 USD 0 us-gaap/2024
0001213900-25-047104 20231231 Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-047104 20231231 Alternative Cashless Exercise Of Common Stock Warrants 5526287.0000 USD 4 0001213900-25-047104
0001213900-25-047104 20240331 Alternative Cashless Exercise Of Common Stock Warrants 57589.0000 USD 1 0001213900-25-047104 Class Of Stock= Common Class C;
0001213900-25-047104 20250331 Alternative Cashless Exercise Of Common Stock Warrants -383.0000 USD 1 0001213900-25-047104 Class Of Stock= Class F Common Stock Warrants; Equity Components= Additional Paid In Capital;
0001213900-25-047104 20250331 Alternative Cashless Exercise Of Common Stock Warrants USD 1 0001213900-25-047104 Class Of Stock= Class F Common Stock Warrants; Equity Components= Retained Earnings;
0001213900-25-047104 20250331 Assets Current 3927881.0000 USD 0 us-gaap/2024
0001213900-25-047104 20250331 Cash And Cash Equivalents At Carrying Value 3704611.0000 USD 0 us-gaap/2024
0001213900-25-047104 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect -2794407.0000 USD 1 us-gaap/2024
0001213900-25-047104 20241231 Common Stock Warrants Exercises 241390.0000 USD 4 0001213900-25-047104 Class Of Stock= Common Class D;
0001213900-25-047104 20241231 Common Stock Warrants Exercises 6.0000 USD 4 0001213900-25-047104 Class Of Stock= Common Class D; Equity Components= Common Stock;
0001213900-25-047104 20241231 Common Stock Warrants Exercises USD 4 0001213900-25-047104 Class Of Stock= Common Class D; Equity Components= Retained Earnings;
0001213900-25-047104 20231231 Deferred Offering Costs Included In Accounts Payable And Accrued Expenses 66033.0000 USD 4 0001213900-25-047104
0001213900-25-047104 20231231 Depreciation 25049.0000 USD 4 us-gaap/2024
0001213900-25-047104 20240331 Depreciation 6262.0000 USD 1 us-gaap/2024
0001213900-25-047104 20250331 Depreciation 7221.0000 USD 1 us-gaap/2024
0001213900-25-047104 20240331 Fair Value Adjustment Of Warrants 68427.0000 USD 1 us-gaap/2024 Equity Components= Class C Common Stock Warrant;
0001213900-25-047104 20250331 Fair Value Adjustment Of Warrants -1417.0000 USD 1 us-gaap/2024
0001213900-25-047104 20250331 General And Administrative Expense 1236157.0000 USD 1 us-gaap/2024
0001213900-25-047104 20240331 Increase Decrease In Deferred Offering Costs -71133.0000 USD 1 0001213900-25-047104
0001213900-25-047104 20241231 Liabilities 1913667.0000 USD 0 us-gaap/2024
0001213900-25-047104 20241231 Liabilities Current 1913667.0000 USD 0 us-gaap/2024
0001213900-25-047104 20241231 Net Cash Provided By Used In Financing Activities 12847764.0000 USD 4 us-gaap/2024
0001213900-25-047104 20240331 Net Cash Provided By Used In Operating Activities -2837969.0000 USD 1 us-gaap/2024
0001213900-25-047104 20240331 Net Income Loss -2681433.0000 USD 1 us-gaap/2024
0001213900-25-047104 20250331 Net Income Loss -2051085.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001213900-25-047104 20231231 Noncash Equity Issuance Costs In Connection With Warrant Inducement Included In Accounts Payable USD 4 0001213900-25-047104
0001213900-25-047104 20231231 Noncash Fair Value Of Common Stock Warrants USD 4 0001213900-25-047104 Equity Components= Class F Common Stock Warrants;
0001213900-25-047104 20241231 Noncash Fair Value Of Common Stock Warrants With Warrant Inducement 4887683.0000 USD 4 0001213900-25-047104 Equity Components= Class E Common Stock Warrants;
0001213900-25-047104 20241231 Noncash Fair Value Of New Common Stock Warrants With Public Offering 6269684.0000 USD 4 0001213900-25-047104 Equity Components= Class D Common Stock Warrants; Subsidiary Sale Of Stock= February2024 Public Offering;
0001213900-25-047104 20231231 Operating Expenses 8656664.0000 USD 4 us-gaap/2024
0001213900-25-047104 20250331 Other Nonoperating Income Expense 42485.0000 USD 1 us-gaap/2024
0001213900-25-047104 20241231 Payments For Repurchase Of Redeemable Preferred Stock USD 4 us-gaap/2024
0001213900-25-047104 20231231 Pre Funded Warrants Exercise USD 4 0001213900-25-047104 Equity Components= Retained Earnings;
0001213900-25-047104 20241231 Pre Funded Warrants Exercise USD 4 0001213900-25-047104 Equity Components= Retained Earnings;
0001213900-25-047104 20240331 Pre Funded Warrants Exercise Shares 77282.0000 shares 1 0001213900-25-047104 Class Of Stock= Common Class D; Equity Components= Common Stock;
0001213900-25-047104 20231231 Proceeds From Issuance Initial Public Offering 14029974.0000 USD 4 us-gaap/2024 Subsidiary Sale Of Stock= February2023 Public Offering;
0001213900-25-047104 20240331 Proceeds From Issuance Initial Public Offering 5417053.0000 USD 1 us-gaap/2024 Subsidiary Sale Of Stock= February2024 Public Offering;
0001213900-25-047104 20241231 Proceeds From Issuance Initial Public Offering 5417053.0000 USD 4 us-gaap/2024 Subsidiary Sale Of Stock= February2024 Public Offering;
0001213900-25-047104 20231231 Proceeds From Warrant Exercises USD 4 us-gaap/2024 Equity Components= Class D Pre Funded Warrants;
0001213900-25-047104 20241130 Proceeds From Warrant Exercises 4100000.0000 USD 0 us-gaap/2024 Equity Components= Class F Common Stock Warrants And The Class G Common Stock Warrants;
0001213900-25-047104 20241231 Proceeds From Warrant Exercises USD 4 us-gaap/2024 Equity Components= Class C Pre Funded Warrants;
0001213900-25-047104 20250331 Retained Earnings Accumulated Deficit -42556723.0000 USD 0 us-gaap/2024
0001213900-25-047104 20221231 Shares Outstanding 4812.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
ddate The end date for the data value, rounded to the nearest month end.
qtrs The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value.
uom The unit of measure for the value.
segments Tags used to represent axis and member reporting.
coreg If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity.
value The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point.
footnote The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank.

Tags

tag version custom abstract datatype iord crdr tlabel doc
Alternative Cashless Of Common Stock Warrants Exercise 0001213900-25-047104 1 0 monetary D C Alternative Cashless Of Common Stock Warrants Exercise Alternative cashless of common stock warrants exercise.
Assets Current us-gaap/2024 0 0 monetary I D Assets, Current Amount of asset recognized for present right to economic benefit, classified as current.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 0 0 monetary I D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Noncash Fair Value Of Common Stock Warrants 0001213900-25-047104 1 0 monetary D D Noncash Fair Value Of Common Stock Warrants Noncash fair value of common stock warrants.
Common Stock Warrants Exercises 0001213900-25-045828 1 0 monetary D C Common Stock Warrants Exercises Common stock warrants exercises.
Warrant Inducement Exercises 0001213900-25-045828 1 0 monetary D C Warrant Inducement Exercises Warrant inducement exercises.
Payments To Acquire Property Plant And Equipment us-gaap/2024 0 0 monetary D C Payments to Acquire Property, Plant, and Equipment The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Stock Issued During Period Shares Restricted Stock Award Gross us-gaap/2024 0 0 shares D Stock Issued During Period, Shares, Restricted Stock Award, Gross Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.
Common Stock Warrants Exercises Shares 0001213900-25-045828 1 0 shares D Common Stock Warrants Exercises Shares Common stock warrants exercises shares.
Pre Funded Warrants Exercise Shares 0000950170-25-066897 1 0 shares D Pre Funded Warrants Exercise Shares Pre funded warrants exercise shares.
Liabilities us-gaap/2024 0 0 monetary I C Liabilities Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.
Liabilities And Stockholders Equity us-gaap/2024 0 0 monetary I C Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Retained Earnings Accumulated Deficit us-gaap/2024 0 0 monetary I C Retained Earnings (Accumulated Deficit) Amount of accumulated undistributed earnings (deficit).
Stock Issued During Period Shares Issued For Services us-gaap/2024 0 0 shares D Stock Issued During Period, Shares, Issued for Services Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.
Alternative Cashless Exercise Of Common Stock Warrants Shares 0000950170-25-066897 1 0 shares D Alternative Cashless Exercise of Common Stock Warrants Shares Alternative cashless exercise of common stock warrants shares.
Warrant Liability 0000950170-25-066897 1 0 monetary I C Warrant Liability Warrant liability.
Alternative Cashless Exercise Of Common Stock Warrants 0001213900-25-047104 1 0 monetary D C Alternative Cashless Exercise Of Common Stock Warrants Alternative cashless exercise of common stock warrants.
Disposal Of Lab Supplies 0001213900-25-045828 1 0 monetary D D Disposal Of Lab Supplies Disposal of lab supplies.
Additional Paid In Capital us-gaap/2024 0 0 monetary I C Additional Paid in Capital Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.
Common Stock Par Or Stated Value Per Share us-gaap/2024 0 0 perShare I Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock.
Common Stock Shares Outstanding us-gaap/2024 0 0 shares I Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Net Income Loss us-gaap/2024 0 0 monetary D C Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Stockholders Equity us-gaap/2024 0 0 monetary I C Equity, Attributable to Parent Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.
Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Diluted The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Disposal Of Lab Supplies 0000950170-25-066897 1 0 monetary D D Disposal of Lab Supplies Disposal of lab supplies.
Alternative Cashless Exercise Of Common Stock Warrants Shares 0001213900-25-045828 1 0 shares D Alternative Cashless Exercise Of Common Stock Warrants Shares Alternative cashless exercise of common stock warrants shares.
Pre Funded Warrants Exercise Shares 0001213900-25-045828 1 0 shares D Pre Funded Warrants Exercise Shares Pre funded warrants exercise shares.
Deferred Underwriting Commissions 0001213900-25-047104 1 0 monetary I C Deferred Underwriting Commissions Deferred underwriting commissions.
Increase Decrease In Deferred Offering Costs 0001213900-25-047104 1 0 monetary D C Increase Decrease In Deferred Offering Costs Amount of changes in deferred offering costs.
Alternative Cashless Exercise Of Class F Common Stock Warrants 0001213900-25-045828 1 0 monetary D C Alternative Cashless Exercise Of Class FCommon Stock Warrants Alternative cashless exercise of Class F Common Stock Warrants.
Assets us-gaap/2024 0 0 monetary I D Assets Amount of asset recognized for present right to economic benefit.
Common Stock Shares Issued us-gaap/2024 0 0 shares I Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Earnings Per Share Diluted us-gaap/2024 0 0 perShare D Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Payments For Repurchase Of Redeemable Preferred Stock us-gaap/2024 0 0 monetary D C Payments for Repurchase of Redeemable Preferred Stock The cash outflow for reacquisition of callable preferred stock.
Issuance Of Class D Common Stock Warrants In Connection With The February2024 Public Offering 0001213900-25-047104 1 0 monetary D C Issuance Of Class DCommon Stock Warrants In Connection With The February2024 Public Offering Issuance of Class D Common Stock Warrants in connection with the February 2024 Public Offering.
Warrant Liability 0001213900-25-047104 1 0 monetary I C Warrant Liability Warrant liability.
Stock Issued During Period Value Retrospective Application Of Reverse Recapitalization 0001213900-25-045828 1 0 monetary D C Stock Issued During Period Value Retrospective Application Of Reverse Recapitalization Value of retrospective application of reverse recapitalization.
Warrant Liability 0001213900-25-045828 1 0 monetary I C Warrant Liability Warrant liability.
Accrued Liabilities Current us-gaap/2024 0 0 monetary I C Accrued Liabilities, Current Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock us-gaap/2024 0 0 monetary D D Adjustments to Additional Paid in Capital, Increase in Carrying Amount of Redeemable Preferred Stock Amount of decrease (increase) in additional paid in capital (APIC) for the increase in carrying amount of redeemable preferred stock.
Liabilities Current us-gaap/2024 0 0 monetary I C Liabilities, Current Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Share Based Compensation us-gaap/2024 0 0 monetary D D Share-Based Payment Arrangement, Noncash Expense Amount of noncash expense for share-based payment arrangement.
Stock Issued During Period Value Issued For Services us-gaap/2024 0 0 monetary D C Stock Issued During Period, Value, Issued for Services Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.
Cash And Cash Equivalents At Carrying Value us-gaap/2024 0 0 monetary I D Cash and Cash Equivalents, at Carrying Value Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Noncash Issuance Of Common Stock Warrants 0000950170-25-066897 1 0 monetary D D Noncash Issuance of Common Stock Warrants Noncash issuance of common stock warrants.
Deferred Underwriting Commissions 0001213900-25-045828 1 0 monetary I C Deferred Underwriting Commissions Deferred underwriting commissions.
Issuance Of Class D Common Stock Warrants In Connection With The February2024 Public Offering 0001213900-25-045828 1 0 monetary D C Issuance Of Class DCommon Stock Warrants In Connection With The February2024 Public Offering Issuance of Class D Common Stock Warrants in connection with the February 2024 Public Offering.
Pre Funded Warrants Exercise 0001213900-25-045828 1 0 monetary D C Pre Funded Warrants Exercise Pre-funded warrants exercise.
Stock Issued During Period Shares Retrospective Application Of Reverse Recapitalization 0001213900-25-045828 1 0 shares D Stock Issued During Period Shares Retrospective Application Of Reverse Recapitalization Number of shares of retrospective application of reverse recapitalization.
Common Stock Warrants Exercises Shares 0001213900-25-047104 1 0 shares D Common Stock Warrants Exercises Shares Common stock warrants exercises shares.
Stock Issued During Period Shares Reverse Stock Split Fractional Stock Round Up 0001213900-25-047104 1 0 shares D Stock Issued During Period Shares Reverse Stock Split Fractional Stock Round Up Number of shares of reverse stock split fractional stock round up.
Stock Issued During Period Value Retrospective Application Of Reverse Recapitalization 0001213900-25-047104 1 0 monetary D C Stock Issued During Period Value Retrospective Application Of Reverse Recapitalization Value of retrospective application of reverse recapitalization.
Pre Funded Warrants Exercise 0001213900-25-047104 1 0 monetary D C Pre Funded Warrants Exercise Pre-funded warrants exercise.
Increase Decrease In Prepaid Deferred Expense And Other Assets us-gaap/2024 0 0 monetary D C Increase (Decrease) in Prepaid Expense and Other Assets Amount of increase (decrease) in prepaid expenses, and assets classified as other.
Nonoperating Income Expense us-gaap/2024 0 0 monetary D C Nonoperating Income (Expense) The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Net Cash Provided By Used In Operating Activities us-gaap/2024 0 0 monetary D Net Cash Provided by (Used in) Operating Activities Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Operating Expenses us-gaap/2024 0 0 monetary D D Operating Expenses Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
Operating Income Loss us-gaap/2024 0 0 monetary D C Operating Income (Loss) The net result for the period of deducting operating expenses from operating revenues.
Prepaid Expense And Other Assets Current us-gaap/2024 0 0 monetary I D Prepaid Expense and Other Assets, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.
Proceeds From Issuance Initial Public Offering us-gaap/2024 0 0 monetary D D Proceeds from Issuance Initial Public Offering The cash inflow associated with the amount received from entity's first offering of stock to the public.
Stock Issued During Period Shares Other us-gaap/2024 0 0 shares D Stock Issued During Period, Shares, Other Number of shares of stock issued attributable to transactions classified as other.
Increase Decrease In Deferred Offering Costs 0000950170-25-066897 1 0 monetary D C IncreaseDecreaseInDeferredOfferingCosts Amount of changes in deferred offering costs.
Deferred Offering Costs Included In Accounts Payable And Accrued Expenses 0001213900-25-045828 1 0 monetary D C Deferred Offering Costs Included In Accounts Payable And Accrued Expenses Deferred offering costs included in accounts payable and accrued expenses.
Alternative Cashless Exercise Of Class F Common Stock Warrants 0001213900-25-047104 1 0 monetary D C Alternative Cashless Exercise Of Class FCommon Stock Warrants Alternative cashless exercise of Class F Common Stock Warrants.
Alternative Cashless Exercise Of Common Stock Warrants Shares 0001213900-25-047104 1 0 shares D Alternative Cashless Exercise Of Common Stock Warrants Shares Alternative cashless exercise of common stock warrants shares.
Noncash Equity Issuance Costs In Connection With Warrant Inducement Included In Accounts Payable 0001213900-25-047104 1 0 monetary D D Noncash Equity Issuance Costs In Connection With Warrant Inducement Included In Accounts Payable Noncash equity issuance costs in connection with warrant inducement included in accounts payable.
Noncash Fair Value Of Common Stock Warrants With Warrant Inducement 0001213900-25-047104 1 0 monetary D D Noncash Fair Value Of Common Stock Warrants With Warrant Inducement Noncash fair value of common stock warrants with warrant inducement.
Warrant Inducement Exercises 0001213900-25-047104 1 0 monetary D C Warrant Inducement Exercises Warrant inducement exercises.
Warrant Inducement Exercises Shares 0001213900-25-047104 1 0 shares D Warrant Inducement Exercises Shares Warrant inducement exercises shares.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect us-gaap/2024 0 0 monetary D D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Common Stock Value us-gaap/2024 0 0 monetary I C Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Deferred Offering Costs us-gaap/2024 0 0 monetary I D Deferred Offering Costs Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.
General And Administrative Expense us-gaap/2024 0 0 monetary D D General and Administrative Expense The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Research And Development Expense us-gaap/2024 0 0 monetary D D Research and Development Expense Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.
Stock Issued During Period Shares New Issues us-gaap/2024 0 0 shares D Stock Issued During Period, Shares, New Issues Number of new stock issued during the period.
Stock Redeemed Or Called During Period Shares us-gaap/2024 0 0 shares D Stock Redeemed or Called During Period, Shares Number of stock bought back by the entity at the exercise price or redemption price.
Noncash Fair Value Of Common Stock Warrants 0001213900-25-045828 1 0 monetary D D Noncash Fair Value Of Common Stock Warrants Noncash fair value of common stock warrants.
Noncash Fair Value Of Common Stock Warrants With Warrant Inducement 0001213900-25-045828 1 0 monetary D D Noncash Fair Value Of Common Stock Warrants With Warrant Inducement Noncash fair value of common stock warrants with warrant inducement.
Stock Issued During Period Shares Retrospective Application Of Reverse Recapitalization 0001213900-25-047104 1 0 shares D Stock Issued During Period Shares Retrospective Application Of Reverse Recapitalization Number of shares of retrospective application of reverse recapitalization.
Accounts Payable Current us-gaap/2024 0 0 monetary I C Accounts Payable, Current Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Commitments And Contingencies us-gaap/2024 0 0 monetary I C Commitments and Contingencies Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
Common Stock Shares Authorized us-gaap/2024 0 0 shares I Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Fair Value Adjustment Of Warrants us-gaap/2024 0 0 monetary D D Fair Value Adjustment of Warrants Amount of expense (income) related to adjustment to fair value of warrant liability.
Increase Decrease In Accounts Payable us-gaap/2024 0 0 monetary D D Increase (Decrease) in Accounts Payable The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.
Net Cash Provided By Used In Financing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Financing Activities Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Shares Outstanding us-gaap/2024 0 0 shares I Shares, Outstanding Number of shares issued which are neither cancelled nor held in the treasury.
Stock Issued During Period Value Restricted Stock Award Gross us-gaap/2024 0 0 monetary D C Stock Issued During Period, Value, Restricted Stock Award, Gross Aggregate value of stock related to Restricted Stock Awards issued during the period.
Pre Funded Warrants Exercise 0000950170-25-066897 1 0 monetary D C Pre Funded Warrants Exercise Pre-funded warrants exercise.
Depreciation us-gaap/2024 0 0 monetary D D Depreciation The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Earnings Per Share Basic us-gaap/2024 0 0 perShare D Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Net Cash Provided By Used In Investing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Investing Activities Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Other Nonoperating Income Expense us-gaap/2024 0 0 monetary D C Other Nonoperating Income (Expense) Amount of income (expense) related to nonoperating activities, classified as other.
Stock Issued During Period Value New Issues us-gaap/2024 0 0 monetary D C Stock Issued During Period, Value, New Issues Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.
Alternative Cashless Exercise Of Common Stock Warrants 0001213900-25-045828 1 0 monetary D C Alternative Cashless Exercise Of Common Stock Warrants Alternative cashless exercise of common stock warrants.
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2024 0 0 monetary D C APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.
Alternative Cashless Exercise Of Common Stock Warrants 0000950170-25-066897 1 0 monetary D C Alternative Cashless Exercise of Common Stock Warrants Alternative cashless exercise of common stock warrants.
Alternative Cashless Of Common Stock Warrants Exercise 0000950170-25-066897 1 0 monetary D C Alternative Cashless of Common Stock Warrants Exercise Alternative cashless of common stock warrants exercise.
Alternative Cashless Of Common Stock Warrants Exercise 0001213900-25-045828 1 0 monetary D C Alternative Cashless Of Common Stock Warrants Exercise Alternative cashless of common stock warrants exercise.
Increase Decrease In Deferred Offering Costs 0001213900-25-045828 1 0 monetary D C Increase Decrease In Deferred Offering Costs Amount of changes in deferred offering costs.
Noncash Equity Issuance Costs In Connection With Warrant Inducement Included In Accounts Payable 0001213900-25-045828 1 0 monetary D D Noncash Equity Issuance Costs In Connection With Warrant Inducement Included In Accounts Payable Noncash equity issuance costs in connection with warrant inducement included in accounts payable.
Noncash Fair Value Of New Common Stock Warrants With Public Offering 0001213900-25-045828 1 0 monetary D D Noncash Fair Value Of New Common Stock Warrants With Public Offering Noncash fair value of new common stock warrants with public offering.
Warrant Inducement Exercises Shares 0001213900-25-045828 1 0 shares D Warrant Inducement Exercises Shares Warrant inducement exercises shares.
Disposal Of Lab Supplies 0001213900-25-047104 1 0 monetary D D Disposal Of Lab Supplies Disposal of lab supplies.
Increase Decrease In Accrued Liabilities us-gaap/2024 0 0 monetary D D Increase (Decrease) in Accrued Liabilities The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.
Issuance Of Stock And Warrants For Services Or Claims us-gaap/2024 0 0 monetary D D Issuance of Stock and Warrants for Services or Claims Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.
Proceeds From Warrant Exercises us-gaap/2024 0 0 monetary D D Proceeds from Warrant Exercises The cash inflow associated with the amount received from holders exercising their stock warrants.
Property Plant And Equipment Net us-gaap/2024 0 0 monetary I D Property, Plant and Equipment, Net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
Stock Issued During Period Value Other us-gaap/2024 0 0 monetary D C Stock Issued During Period, Value, Other Value of shares of stock issued attributable to transactions classified as other.
Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Stock Issued During Period Shares Reverse Stock Split Fractional Stock Round Up 0001213900-25-045828 1 0 shares D Stock Issued During Period Shares Reverse Stock Split Fractional Stock Round Up Number of shares of reverse stock split fractional stock round up.
Common Stock Warrants Exercises 0001213900-25-047104 1 0 monetary D C Common Stock Warrants Exercises Common stock warrants exercises.
Deferred Offering Costs Included In Accounts Payable And Accrued Expenses 0001213900-25-047104 1 0 monetary D C Deferred Offering Costs Included In Accounts Payable And Accrued Expenses Deferred offering costs included in accounts payable and accrued expenses.
Noncash Fair Value Of New Common Stock Warrants With Public Offering 0001213900-25-047104 1 0 monetary D D Noncash Fair Value Of New Common Stock Warrants With Public Offering Noncash fair value of new common stock warrants with public offering.
Pre Funded Warrants Exercise Shares 0001213900-25-047104 1 0 shares D Pre Funded Warrants Exercise Shares Pre funded warrants exercise shares.

Description
Field Name Field Description
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
custom 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns.
abstract 1 if the tag is not used to represent a numeric fact.
datatype If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag.
iord If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration.
crdr If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL.
tlabel If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here.
doc The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL.

Presentation of Statements

adsh report line stmt inpth rfile tag version plabel negating
0001213900-25-047104 2 6 BS 0 H Cash And Cash Equivalents At Carrying Value us-gaap/2024 Cash and cash equivalents 0
0001213900-25-045828 2 6 BS 0 H Cash And Cash Equivalents At Carrying Value us-gaap/2024 Cash and cash equivalents 0
0001213900-25-045828 2 7 BS 0 H Deferred Offering Costs us-gaap/2024 Deferred offering costs 0
0001213900-25-045828 2 8 BS 0 H Prepaid Expense And Other Assets Current us-gaap/2024 Prepaid expenses and other current assets 0
0001213900-25-045828 2 9 BS 0 H Assets Current us-gaap/2024 Total current assets 0
0001213900-25-045828 2 10 BS 0 H Property Plant And Equipment Net us-gaap/2024 Property and equipment, net 0
0001213900-25-045828 2 11 BS 0 H Assets us-gaap/2024 Total assets 0
0001213900-25-045828 2 13 BS 0 H Accounts Payable Current us-gaap/2024 Accounts payable 0
0001213900-25-045828 2 14 BS 0 H Accrued Liabilities Current us-gaap/2024 Accrued expenses 0
0001213900-25-045828 2 15 BS 0 H Deferred Underwriting Commissions 0001213900-25-045828 Deferred underwriting commissions 0
0001213900-25-045828 2 16 BS 0 H Warrant Liability 0001213900-25-045828 Warrant liability 0
0001213900-25-045828 2 17 BS 0 H Liabilities Current us-gaap/2024 Total current liabilities 0
0001213900-25-045828 2 18 BS 0 H Liabilities us-gaap/2024 Total liabilities 0
0001213900-25-045828 2 19 BS 0 H Commitments And Contingencies us-gaap/2024 Commitments and Contingencies (Note 4) 0
0001213900-25-045828 2 20 BS 0 H Common Stock Value us-gaap/2024 Common Stock, value 0
0001213900-25-045828 2 21 BS 0 H Additional Paid In Capital us-gaap/2024 Additional paid-in-capital 0
0001213900-25-045828 2 22 BS 0 H Retained Earnings Accumulated Deficit us-gaap/2024 Accumulated deficit 0
0001213900-25-045828 2 23 BS 0 H Stockholders Equity us-gaap/2024 Total stockholders equity 0
0001213900-25-045828 2 24 BS 0 H Liabilities And Stockholders Equity us-gaap/2024 Total liabilities and stockholders equity 0
0001213900-25-045828 3 5 BS 1 H Common Stock Par Or Stated Value Per Share us-gaap/2024 Common stock, par value (in Dollars per share) 0
0001213900-25-045828 3 6 BS 1 H Common Stock Shares Authorized us-gaap/2024 Common stock, shares authorized 0
0001213900-25-045828 3 7 BS 1 H Common Stock Shares Issued us-gaap/2024 Common stock, shares issued 0
0001213900-25-045828 3 8 BS 1 H Common Stock Shares Outstanding us-gaap/2024 Common stock, shares outstanding 0
0001213900-25-045828 4 2 IS 0 H Research And Development Expense us-gaap/2024 Research and development 0
0001213900-25-045828 4 3 IS 0 H General And Administrative Expense us-gaap/2024 General and administrative 0
0001213900-25-045828 4 4 IS 0 H Operating Expenses us-gaap/2024 Total operating expenses 0
0001213900-25-045828 4 5 IS 0 H Operating Income Loss us-gaap/2024 Loss from operations 0
0001213900-25-045828 4 7 IS 0 H Fair Value Adjustment Of Warrants us-gaap/2024 Change in fair value of warrant liability 1
0001213900-25-045828 4 8 IS 0 H Other Nonoperating Income Expense us-gaap/2024 Other income (expense), net 0
0001213900-25-045828 4 9 IS 0 H Nonoperating Income Expense us-gaap/2024 Total other income (expense), net 0
0001213900-25-045828 4 10 IS 0 H Net Income Loss us-gaap/2024 Net loss 0
0001213900-25-045828 4 11 IS 0 H Earnings Per Share Diluted us-gaap/2024 Net loss per share, basic (in Dollars per share) 0
0001213900-25-045828 4 12 IS 0 H Earnings Per Share Basic us-gaap/2024 Net loss per share, diluted (in Dollars per share) 0
0001213900-25-045828 4 13 IS 0 H Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 Weighted-average shares used to compute net loss per share, basic (in Shares) 0
0001213900-25-045828 4 14 IS 0 H Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 Weighted-average shares used to compute net loss per share, diluted (in Shares) 0
0001213900-25-045828 5 21 EQ 0 H Shares Outstanding us-gaap/2024 Balance (in Shares) 0
0001213900-25-045828 5 22 EQ 0 H Stockholders Equity us-gaap/2024 Balance 0
0001213900-25-045828 5 23 EQ 0 H Stock Issued During Period Shares Retrospective Application Of Reverse Recapitalization 0001213900-25-045828 Retrospective application of reverse recapitalization (in Shares) 0
0001213900-25-045828 5 24 EQ 0 H Stock Issued During Period Value Retrospective Application Of Reverse Recapitalization 0001213900-25-045828 Retrospective application of reverse recapitalization 0
0001213900-25-045828 5 25 EQ 0 H Stock Issued During Period Shares Reverse Stock Split Fractional Stock Round Up 0001213900-25-045828 Reverse stock split fractional stock round up (in Shares) 0
0001213900-25-045828 5 26 EQ 0 H Stock Redeemed Or Called During Period Shares us-gaap/2024 Redemption of Series A Preferred Stock (in Shares) 0
0001213900-25-045828 5 27 EQ 0 H Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock us-gaap/2024 Redemption of Series A Preferred Stock 0
0001213900-25-045828 5 28 EQ 0 H Stock Issued During Period Shares New Issues us-gaap/2024 Issuance of common stock from the February 2024 Public Offering (in Shares) 0
0001213900-25-045828 5 29 EQ 0 H Stock Issued During Period Value New Issues us-gaap/2024 Issuance of common stock from the February 2024 Public Offering 0
0001213900-25-045828 5 30 EQ 0 H Pre Funded Warrants Exercise Shares 0001213900-25-045828 Class D Pre-Funded Warrants exercise (in Shares) 0
0001213900-25-045828 5 31 EQ 0 H Pre Funded Warrants Exercise 0001213900-25-045828 Class D Pre-Funded Warrants exercise 0
0001213900-25-045828 5 32 EQ 0 H Alternative Cashless Exercise Of Common Stock Warrants Shares 0001213900-25-045828 Alternative cashless exercise of Class C Common Stock Warrants (in Shares) 0
0001213900-25-045828 5 33 EQ 0 H Alternative Cashless Exercise Of Common Stock Warrants 0001213900-25-045828 Alternative cashless exercise of Class C Common Stock Warrants 0
0001213900-25-045828 5 34 EQ 0 H Stock Issued During Period Value Other us-gaap/2024 Issuance of RSAs 0
0001213900-25-045828 5 35 EQ 0 H Stock Issued During Period Shares Other us-gaap/2024 Issuance of RSAs (in Shares) 0
0001213900-25-045828 5 36 EQ 0 H Stock Issued During Period Shares Issued For Services us-gaap/2024 Common stock issued for services (in Shares) 0
0001213900-25-045828 5 37 EQ 0 H Stock Issued During Period Value Issued For Services us-gaap/2024 Common stock issued for services 0
0001213900-25-045828 5 38 EQ 0 H Common Stock Warrants Exercises Shares 0001213900-25-045828 Class D Common Stock Warrants exercises (in Shares) 0
0001213900-25-045828 5 39 EQ 0 H Common Stock Warrants Exercises 0001213900-25-045828 Class D Common Stock Warrants exercises 0
0001213900-25-045828 5 40 EQ 0 H Warrant Inducement Exercises Shares 0001213900-25-045828 Class D Warrant Inducement exercises (in Shares) 0
0001213900-25-045828 5 41 EQ 0 H Warrant Inducement Exercises 0001213900-25-045828 Class D Warrant Inducement exercises 0
0001213900-25-045828 5 42 EQ 0 H Stock Issued During Period Shares Restricted Stock Award Gross us-gaap/2024 RSU awards issued (in Shares) 0
0001213900-25-045828 5 43 EQ 0 H Stock Issued During Period Value Restricted Stock Award Gross us-gaap/2024 RSU awards issued 0
0001213900-25-045828 5 44 EQ 0 H Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2024 Stock-based compensation expense 0
0001213900-25-045828 5 45 EQ 0 H Net Income Loss us-gaap/2024 Net loss 0
0001213900-25-045828 5 46 EQ 0 H Shares Outstanding us-gaap/2024 Balance (in Shares) 0
0001213900-25-045828 5 47 EQ 0 H Stockholders Equity us-gaap/2024 Balance 0
0001213900-25-045828 6 18 CF 0 H Net Income Loss us-gaap/2024 Net loss 0
0001213900-25-045828 6 20 CF 0 H Share Based Compensation us-gaap/2024 Stock-based compensation expense 0
0001213900-25-045828 6 21 CF 0 H Issuance Of Stock And Warrants For Services Or Claims us-gaap/2024 Issuance of common stock for services 0
0001213900-25-045828 6 22 CF 0 H Depreciation us-gaap/2024 Depreciation expense 0
0001213900-25-045828 6 23 CF 0 H Disposal Of Lab Supplies 0001213900-25-045828 Disposal of lab supplies 0
0001213900-25-045828 6 24 CF 0 H Fair Value Adjustment Of Warrants us-gaap/2024 Change in fair value of warrant liability 0
0001213900-25-045828 6 26 CF 0 H Increase Decrease In Prepaid Deferred Expense And Other Assets us-gaap/2024 Prepaid expenses and other current assets 1
0001213900-25-045828 6 27 CF 0 H Increase Decrease In Deferred Offering Costs 0001213900-25-045828 Deferred offering costs 1
0001213900-25-045828 6 28 CF 0 H Increase Decrease In Accounts Payable us-gaap/2024 Accounts payable 0
0001213900-25-045828 6 29 CF 0 H Increase Decrease In Accrued Liabilities us-gaap/2024 Accrued expenses 0
0001213900-25-045828 6 30 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2024 Net cash used in operating activities 0
0001213900-25-045828 6 32 CF 0 H Payments To Acquire Property Plant And Equipment us-gaap/2024 Purchase of property and equipment 1
0001213900-25-045828 6 33 CF 0 H Net Cash Provided By Used In Investing Activities us-gaap/2024 Net cash used in investing activities 0
0001213900-25-045828 6 35 CF 0 H Proceeds From Issuance Initial Public Offering us-gaap/2024 Proceeds from the February Public Offering, net 0
0001213900-25-045828 6 36 CF 0 H Proceeds From Warrant Exercises us-gaap/2024 Proceeds from Warrant exercise 0
0001213900-25-045828 6 37 CF 0 H Net Cash Provided By Used In Financing Activities us-gaap/2024 Net cash provided by financing activities 0
0001213900-25-045828 6 38 CF 0 H Payments For Repurchase Of Redeemable Preferred Stock us-gaap/2024 Redemption of Series A Preferred Stock 1
0001213900-25-045828 6 39 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect us-gaap/2024 Net (decrease) increase in cash and cash equivalents 0
0001213900-25-045828 6 40 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash and cash equivalents at beginning of period 0
0001213900-25-045828 6 41 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash and cash equivalents at end of period 0
0001213900-25-045828 6 43 CF 0 H Noncash Fair Value Of Common Stock Warrants 0001213900-25-045828 Fair Value of Common Stock Warrants 0
0001213900-25-045828 6 44 CF 0 H Noncash Fair Value Of Common Stock Warrants With Warrant Inducement 0001213900-25-045828 Incremental fair value of the Common Stock Warrants in connection with the Warrant Inducement 0
0001213900-25-045828 6 45 CF 0 H Noncash Equity Issuance Costs In Connection With Warrant Inducement Included In Accounts Payable 0001213900-25-045828 Equity issuance costs in connection with the Class D Warrant Inducement included in accounts payable 0
0001213900-25-045828 6 46 CF 0 H Noncash Fair Value Of New Common Stock Warrants With Public Offering 0001213900-25-045828 Fair Value of Common Stock Warrants in connection with Public Offering 0
0001213900-25-045828 6 47 CF 0 H Issuance Of Class D Common Stock Warrants In Connection With The February2024 Public Offering 0001213900-25-045828 Issuance of Class D Common Stock Warrants in connection with the February 2024 Public Offering 0
0001213900-25-045828 6 48 CF 0 H Alternative Cashless Of Common Stock Warrants Exercise 0001213900-25-045828 Alternative cashless exercise of Class C Common Stock Warrants 0
0001213900-25-045828 6 49 CF 0 H Alternative Cashless Exercise Of Class F Common Stock Warrants 0001213900-25-045828 Alternative cashless exercise of Class F Common Stock Warrants 0
0001213900-25-045828 6 50 CF 0 H Deferred Offering Costs Included In Accounts Payable And Accrued Expenses 0001213900-25-045828 Deferred offering costs included in accounts payable and accrued expenses 0
0000950170-25-066897 2 5 BS 0 H Cash And Cash Equivalents At Carrying Value us-gaap/2024 Cash and cash equivalents 0
0000950170-25-066897 2 6 BS 0 H Prepaid Expense And Other Assets Current us-gaap/2024 Prepaid expenses and other current assets 0
0000950170-25-066897 2 7 BS 0 H Assets Current us-gaap/2024 Total current assets 0
0000950170-25-066897 2 8 BS 0 H Property Plant And Equipment Net us-gaap/2024 Property and equipment, net 0
0000950170-25-066897 2 9 BS 0 H Assets us-gaap/2024 Total assets 0
0000950170-25-066897 2 12 BS 0 H Accounts Payable Current us-gaap/2024 Accounts payable 0
0000950170-25-066897 2 13 BS 0 H Accrued Liabilities Current us-gaap/2024 Accrued expenses 0
0000950170-25-066897 2 14 BS 0 H Warrant Liability 0000950170-25-066897 Warrant liability 0
0000950170-25-066897 2 15 BS 0 H Liabilities Current us-gaap/2024 Total current liabilities 0
0000950170-25-066897 2 16 BS 0 H Liabilities us-gaap/2024 Total liabilities 0
0000950170-25-066897 2 17 BS 0 H Commitments And Contingencies us-gaap/2024 Commitments and Contingencies (Note 4) 0
0000950170-25-066897 2 19 BS 0 H Common Stock Value us-gaap/2024 Common Stock, $0.001 par value 500,000,000 shares authorized 963,796 and 522,223 issued and outstanding at March 31, 2025 and December 31, 2024, respectively 0
0000950170-25-066897 2 20 BS 0 H Additional Paid In Capital us-gaap/2024 Additional paid-in-capital 0
0000950170-25-066897 2 21 BS 0 H Retained Earnings Accumulated Deficit us-gaap/2024 Accumulated deficit 0
0000950170-25-066897 2 22 BS 0 H Stockholders Equity us-gaap/2024 Total stockholders' equity 0
0000950170-25-066897 2 23 BS 0 H Liabilities And Stockholders Equity us-gaap/2024 Total liabilities and stockholders' equity 0
0000950170-25-066897 3 1 BS 1 H Common Stock Par Or Stated Value Per Share us-gaap/2024 Common stock, par value (in Dollars per share) 0
0000950170-25-066897 3 2 BS 1 H Common Stock Shares Authorized us-gaap/2024 Common stock, shares authorized 0
0000950170-25-066897 3 3 BS 1 H Common Stock Shares Issued us-gaap/2024 Common stock, shares issued 0
0000950170-25-066897 3 4 BS 1 H Common Stock Shares Outstanding us-gaap/2024 Common stock, shares outstanding 0
0000950170-25-066897 4 2 IS 0 H Research And Development Expense us-gaap/2024 Research and development 0
0000950170-25-066897 4 3 IS 0 H General And Administrative Expense us-gaap/2024 General and administrative 0
0000950170-25-066897 4 4 IS 0 H Operating Expenses us-gaap/2024 Total operating expenses 0
0000950170-25-066897 4 5 IS 0 H Operating Income Loss us-gaap/2024 Loss from operations 0
0000950170-25-066897 4 7 IS 0 H Fair Value Adjustment Of Warrants us-gaap/2024 Change in fair value of warrant liability 1
0000950170-25-066897 4 8 IS 0 H Other Nonoperating Income Expense us-gaap/2024 Other income (expense), net 0
0000950170-25-066897 4 9 IS 0 H Nonoperating Income Expense us-gaap/2024 Total other income (expense), net 0
0000950170-25-066897 4 10 IS 0 H Net Income Loss us-gaap/2024 Net loss 0
0000950170-25-066897 4 11 IS 0 H Earnings Per Share Basic us-gaap/2024 Net loss per share, basic 0
0000950170-25-066897 4 12 IS 0 H Earnings Per Share Diluted us-gaap/2024 Net loss per share, diluted 0
0000950170-25-066897 4 13 IS 0 H Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 Weighted-average shares used to compute net loss per share, basic 0
0000950170-25-066897 4 14 IS 0 H Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 Weighted-average shares used to compute net loss per share, diluted 0
0000950170-25-066897 5 20 EQ 0 H Stockholders Equity us-gaap/2024 Balance 0
0000950170-25-066897 5 21 EQ 0 H Shares Outstanding us-gaap/2024 Balance (in Shares) 0
0000950170-25-066897 5 22 EQ 0 H Stock Issued During Period Value New Issues us-gaap/2024 Issuance of common stock 0
0000950170-25-066897 5 23 EQ 0 H Stock Issued During Period Shares New Issues us-gaap/2024 Issuance of common stock (Shares) 0
0000950170-25-066897 5 24 EQ 0 H Pre Funded Warrants Exercise 0000950170-25-066897 Pre-Funded Warrants Exercise 0
0000950170-25-066897 5 25 EQ 0 H Pre Funded Warrants Exercise Shares 0000950170-25-066897 Pre-Funded Warrants Exercise (in Shares) 0
0000950170-25-066897 5 26 EQ 0 H Alternative Cashless Exercise Of Common Stock Warrants 0000950170-25-066897 Alternative cashless exercise of common stock warrants 0
0000950170-25-066897 5 27 EQ 0 H Alternative Cashless Exercise Of Common Stock Warrants Shares 0000950170-25-066897 Alternative cashless exercise of common stock warrants (in Shares) 0
0000950170-25-066897 5 28 EQ 0 H Stock Issued During Period Value Restricted Stock Award Gross us-gaap/2024 Issuance of RSA's 0
0000950170-25-066897 5 29 EQ 0 H Stock Issued During Period Shares Restricted Stock Award Gross us-gaap/2024 Issuance of RSA's, Shares 0
0000950170-25-066897 5 30 EQ 0 H Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2024 Stock-based compensation expense 0
0000950170-25-066897 5 31 EQ 0 H Net Income Loss us-gaap/2024 Net income (loss) 0
0000950170-25-066897 5 32 EQ 0 H Stockholders Equity us-gaap/2024 Balance 0
0000950170-25-066897 5 33 EQ 0 H Shares Outstanding us-gaap/2024 Balance (in Shares) 0
0000950170-25-066897 6 15 CF 0 H Net Income Loss us-gaap/2024 Net Income (Loss) 0
0000950170-25-066897 6 17 CF 0 H Fair Value Adjustment Of Warrants us-gaap/2024 Change in fair value of warrant liability 0
0000950170-25-066897 6 18 CF 0 H Depreciation us-gaap/2024 Depreciation expense 0
0000950170-25-066897 6 19 CF 0 H Disposal Of Lab Supplies 0000950170-25-066897 Disposal of lab supplies 0
0000950170-25-066897 6 20 CF 0 H Share Based Compensation us-gaap/2024 Stock-based compensation expense 0
0000950170-25-066897 6 22 CF 0 H Increase Decrease In Accounts Payable us-gaap/2024 Accounts payable 0
0000950170-25-066897 6 23 CF 0 H Increase Decrease In Accrued Liabilities us-gaap/2024 Accrued expenses 0
0000950170-25-066897 6 24 CF 0 H Increase Decrease In Deferred Offering Costs 0000950170-25-066897 Deferred offering costs 1
0000950170-25-066897 6 25 CF 0 H Increase Decrease In Prepaid Deferred Expense And Other Assets us-gaap/2024 Prepaid expenses and other current assets 1
0000950170-25-066897 6 26 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2024 Net cash used in operating activities 0
0000950170-25-066897 6 28 CF 0 H Payments To Acquire Property Plant And Equipment us-gaap/2024 Purchase of property and equipment 1
0000950170-25-066897 6 29 CF 0 H Net Cash Provided By Used In Investing Activities us-gaap/2024 Net cash used in investing activities 0
0000950170-25-066897 6 31 CF 0 H Proceeds From Issuance Initial Public Offering us-gaap/2024 Proceeds from Public Offering, net 0
0000950170-25-066897 6 32 CF 0 H Proceeds From Warrant Exercises us-gaap/2024 Proceeds from Warrant exercise 0
0000950170-25-066897 6 33 CF 0 H Net Cash Provided By Used In Financing Activities us-gaap/2024 Net cash provided by financing activities 0
0000950170-25-066897 6 34 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect us-gaap/2024 Net (decrease) increase in cash and cash equivalents 0
0000950170-25-066897 6 35 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash and cash equivalents at beginning of period 0
0000950170-25-066897 6 36 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash and cash equivalents at end of period 0
0000950170-25-066897 6 38 CF 0 H Noncash Issuance Of Common Stock Warrants 0000950170-25-066897 Noncash issuance of common stock warrants 0
0000950170-25-066897 6 39 CF 0 H Alternative Cashless Of Common Stock Warrants Exercise 0000950170-25-066897 Alternative cashless exercise of Common Stock Warrants 0
0001213900-25-047104 2 7 BS 0 H Deferred Offering Costs us-gaap/2024 Deferred offering costs 0
0001213900-25-047104 2 8 BS 0 H Prepaid Expense And Other Assets Current us-gaap/2024 Prepaid expenses and other current assets 0
0001213900-25-047104 2 9 BS 0 H Assets Current us-gaap/2024 Total current assets 0
0001213900-25-047104 2 10 BS 0 H Property Plant And Equipment Net us-gaap/2024 Property and equipment, net 0
0001213900-25-047104 2 11 BS 0 H Assets us-gaap/2024 Total assets 0
0001213900-25-047104 2 13 BS 0 H Accounts Payable Current us-gaap/2024 Accounts payable 0
0001213900-25-047104 2 14 BS 0 H Accrued Liabilities Current us-gaap/2024 Accrued expenses 0
0001213900-25-047104 2 15 BS 0 H Deferred Underwriting Commissions 0001213900-25-047104 Deferred underwriting commissions 0
0001213900-25-047104 2 16 BS 0 H Warrant Liability 0001213900-25-047104 Warrant liability 0
0001213900-25-047104 2 17 BS 0 H Liabilities Current us-gaap/2024 Total current liabilities 0
0001213900-25-047104 2 18 BS 0 H Liabilities us-gaap/2024 Total liabilities 0
0001213900-25-047104 2 19 BS 0 H Commitments And Contingencies us-gaap/2024 Commitments and Contingencies (Note 4) 0
0001213900-25-047104 2 20 BS 0 H Common Stock Value us-gaap/2024 Common Stock, value 0
0001213900-25-047104 2 21 BS 0 H Additional Paid In Capital us-gaap/2024 Additional paid-in-capital 0
0001213900-25-047104 2 22 BS 0 H Retained Earnings Accumulated Deficit us-gaap/2024 Accumulated deficit 0
0001213900-25-047104 2 23 BS 0 H Stockholders Equity us-gaap/2024 Total stockholders equity 0
0001213900-25-047104 2 24 BS 0 H Liabilities And Stockholders Equity us-gaap/2024 Total liabilities and stockholders equity 0
0001213900-25-047104 3 5 BS 1 H Common Stock Par Or Stated Value Per Share us-gaap/2024 Common stock, par value (in Dollars per share) 0
0001213900-25-047104 3 6 BS 1 H Common Stock Shares Authorized us-gaap/2024 Common stock, shares authorized 0
0001213900-25-047104 3 7 BS 1 H Common Stock Shares Issued us-gaap/2024 Common stock, shares issued 0
0001213900-25-047104 3 8 BS 1 H Common Stock Shares Outstanding us-gaap/2024 Common stock, shares outstanding 0
0001213900-25-047104 4 2 IS 0 H Research And Development Expense us-gaap/2024 Research and development 0
0001213900-25-047104 4 3 IS 0 H General And Administrative Expense us-gaap/2024 General and administrative 0
0001213900-25-047104 4 4 IS 0 H Operating Expenses us-gaap/2024 Total operating expenses 0
0001213900-25-047104 4 5 IS 0 H Operating Income Loss us-gaap/2024 Loss from operations 0
0001213900-25-047104 4 7 IS 0 H Fair Value Adjustment Of Warrants us-gaap/2024 Change in fair value of warrant liability 1
0001213900-25-047104 4 8 IS 0 H Other Nonoperating Income Expense us-gaap/2024 Other income (expense), net 0
0001213900-25-047104 4 9 IS 0 H Nonoperating Income Expense us-gaap/2024 Total other income (expense), net 0
0001213900-25-047104 4 10 IS 0 H Net Income Loss us-gaap/2024 Net loss 0
0001213900-25-047104 4 11 IS 0 H Earnings Per Share Diluted us-gaap/2024 Net loss per share, basic (in Dollars per share) 0
0001213900-25-047104 4 12 IS 0 H Earnings Per Share Basic us-gaap/2024 Net loss per share, diluted (in Dollars per share) 0
0001213900-25-047104 4 13 IS 0 H Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 Weighted-average shares used to compute net loss per share, basic (in Shares) 0
0001213900-25-047104 4 14 IS 0 H Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 Weighted-average shares used to compute net loss per share, diluted (in Shares) 0
0001213900-25-047104 5 21 EQ 0 H Shares Outstanding us-gaap/2024 Balance (in Shares) 0
0001213900-25-047104 5 22 EQ 0 H Stockholders Equity us-gaap/2024 Balance 0
0001213900-25-047104 5 23 EQ 0 H Stock Issued During Period Shares Retrospective Application Of Reverse Recapitalization 0001213900-25-047104 Retrospective application of reverse recapitalization (in Shares) 0
0001213900-25-047104 5 24 EQ 0 H Stock Issued During Period Value Retrospective Application Of Reverse Recapitalization 0001213900-25-047104 Retrospective application of reverse recapitalization 0
0001213900-25-047104 5 25 EQ 0 H Stock Issued During Period Shares Reverse Stock Split Fractional Stock Round Up 0001213900-25-047104 Reverse stock split fractional stock round up (in Shares) 0
0001213900-25-047104 5 26 EQ 0 H Stock Redeemed Or Called During Period Shares us-gaap/2024 Redemption of Series A Preferred Stock (in Shares) 0
0001213900-25-047104 5 27 EQ 0 H Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock us-gaap/2024 Redemption of Series A Preferred Stock 0
0001213900-25-047104 5 28 EQ 0 H Stock Issued During Period Shares New Issues us-gaap/2024 Issuance of common stock from the February 2024 Public Offering (in Shares) 0
0001213900-25-047104 5 29 EQ 0 H Stock Issued During Period Value New Issues us-gaap/2024 Issuance of common stock from the February 2024 Public Offering 0
0001213900-25-047104 5 30 EQ 0 H Pre Funded Warrants Exercise Shares 0001213900-25-047104 Class D Pre-Funded Warrants exercise (in Shares) 0
0001213900-25-047104 5 31 EQ 0 H Pre Funded Warrants Exercise 0001213900-25-047104 Class D Pre-Funded Warrants exercise 0
0001213900-25-047104 5 32 EQ 0 H Alternative Cashless Exercise Of Common Stock Warrants Shares 0001213900-25-047104 Alternative cashless exercise of Class C Common Stock Warrants (in Shares) 0
0001213900-25-047104 5 33 EQ 0 H Alternative Cashless Exercise Of Common Stock Warrants 0001213900-25-047104 Alternative cashless exercise of Class C Common Stock Warrants 0
0001213900-25-047104 5 34 EQ 0 H Stock Issued During Period Value Other us-gaap/2024 Issuance of RSAs 0
0001213900-25-047104 5 35 EQ 0 H Stock Issued During Period Shares Other us-gaap/2024 Issuance of RSAs (in Shares) 0
0001213900-25-047104 5 36 EQ 0 H Stock Issued During Period Shares Issued For Services us-gaap/2024 Common stock issued for services (in Shares) 0
0001213900-25-047104 5 37 EQ 0 H Stock Issued During Period Value Issued For Services us-gaap/2024 Common stock issued for services 0
0001213900-25-047104 5 38 EQ 0 H Common Stock Warrants Exercises Shares 0001213900-25-047104 Class D Common Stock Warrants exercises (in Shares) 0
0001213900-25-047104 5 39 EQ 0 H Common Stock Warrants Exercises 0001213900-25-047104 Class D Common Stock Warrants exercises 0
0001213900-25-047104 5 40 EQ 0 H Warrant Inducement Exercises Shares 0001213900-25-047104 Class D Warrant Inducement exercises (in Shares) 0
0001213900-25-047104 5 41 EQ 0 H Warrant Inducement Exercises 0001213900-25-047104 Class D Warrant Inducement exercises 0
0001213900-25-047104 5 42 EQ 0 H Stock Issued During Period Shares Restricted Stock Award Gross us-gaap/2024 RSU awards issued (in Shares) 0
0001213900-25-047104 5 43 EQ 0 H Stock Issued During Period Value Restricted Stock Award Gross us-gaap/2024 RSU awards issued 0
0001213900-25-047104 5 44 EQ 0 H Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2024 Stock-based compensation expense 0
0001213900-25-047104 5 45 EQ 0 H Net Income Loss us-gaap/2024 Net loss 0
0001213900-25-047104 5 46 EQ 0 H Shares Outstanding us-gaap/2024 Balance (in Shares) 0
0001213900-25-047104 5 47 EQ 0 H Stockholders Equity us-gaap/2024 Balance 0
0001213900-25-047104 6 18 CF 0 H Net Income Loss us-gaap/2024 Net loss 0
0001213900-25-047104 6 20 CF 0 H Share Based Compensation us-gaap/2024 Stock-based compensation expense 0
0001213900-25-047104 6 21 CF 0 H Issuance Of Stock And Warrants For Services Or Claims us-gaap/2024 Issuance of common stock for services 0
0001213900-25-047104 6 22 CF 0 H Depreciation us-gaap/2024 Depreciation expense 0
0001213900-25-047104 6 23 CF 0 H Disposal Of Lab Supplies 0001213900-25-047104 Disposal of lab supplies 0
0001213900-25-047104 6 24 CF 0 H Fair Value Adjustment Of Warrants us-gaap/2024 Change in fair value of warrant liability 0
0001213900-25-047104 6 26 CF 0 H Increase Decrease In Prepaid Deferred Expense And Other Assets us-gaap/2024 Prepaid expenses and other current assets 1
0001213900-25-047104 6 27 CF 0 H Increase Decrease In Deferred Offering Costs 0001213900-25-047104 Deferred offering costs 1
0001213900-25-047104 6 28 CF 0 H Increase Decrease In Accounts Payable us-gaap/2024 Accounts payable 0
0001213900-25-047104 6 29 CF 0 H Increase Decrease In Accrued Liabilities us-gaap/2024 Accrued expenses 0
0001213900-25-047104 6 30 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2024 Net cash used in operating activities 0
0001213900-25-047104 6 32 CF 0 H Payments To Acquire Property Plant And Equipment us-gaap/2024 Purchase of property and equipment 1
0001213900-25-047104 6 33 CF 0 H Net Cash Provided By Used In Investing Activities us-gaap/2024 Net cash used in investing activities 0
0001213900-25-047104 6 35 CF 0 H Proceeds From Issuance Initial Public Offering us-gaap/2024 Proceeds from the February Public Offering, net 0
0001213900-25-047104 6 36 CF 0 H Proceeds From Warrant Exercises us-gaap/2024 Proceeds from Warrant exercise 0
0001213900-25-047104 6 37 CF 0 H Net Cash Provided By Used In Financing Activities us-gaap/2024 Net cash provided by financing activities 0
0001213900-25-047104 6 38 CF 0 H Payments For Repurchase Of Redeemable Preferred Stock us-gaap/2024 Redemption of Series A Preferred Stock 1
0001213900-25-047104 6 39 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect us-gaap/2024 Net (decrease) increase in cash and cash equivalents 0
0001213900-25-047104 6 40 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash and cash equivalents at beginning of period 0
0001213900-25-047104 6 41 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash and cash equivalents at end of period 0
0001213900-25-047104 6 43 CF 0 H Noncash Fair Value Of Common Stock Warrants 0001213900-25-047104 Fair Value of Common Stock Warrants 0
0001213900-25-047104 6 44 CF 0 H Noncash Fair Value Of Common Stock Warrants With Warrant Inducement 0001213900-25-047104 Incremental fair value of the Common Stock Warrants in connection with the Warrant Inducement 0
0001213900-25-047104 6 45 CF 0 H Noncash Equity Issuance Costs In Connection With Warrant Inducement Included In Accounts Payable 0001213900-25-047104 Equity issuance costs in connection with the Class D Warrant Inducement included in accounts payable 0
0001213900-25-047104 6 46 CF 0 H Noncash Fair Value Of New Common Stock Warrants With Public Offering 0001213900-25-047104 Fair Value of Common Stock Warrants in connection with Public Offering 0
0001213900-25-047104 6 47 CF 0 H Issuance Of Class D Common Stock Warrants In Connection With The February2024 Public Offering 0001213900-25-047104 Issuance of Class D Common Stock Warrants in connection with the February 2024 Public Offering 0
0001213900-25-047104 6 48 CF 0 H Alternative Cashless Of Common Stock Warrants Exercise 0001213900-25-047104 Alternative cashless exercise of Class C Common Stock Warrants 0
0001213900-25-047104 6 49 CF 0 H Alternative Cashless Exercise Of Class F Common Stock Warrants 0001213900-25-047104 Alternative cashless exercise of Class F Common Stock Warrants 0
0001213900-25-047104 6 50 CF 0 H Deferred Offering Costs Included In Accounts Payable And Accrued Expenses 0001213900-25-047104 Deferred offering costs included in accounts payable and accrued expenses 0

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
report Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site.
line Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived.
stmt The financial statement location to which the value of the “report” field pertains.
inpth Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700.
rfile The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file.
tag The tag chosen by the filer for this line item.
version The taxonomy identifier if the tag is a standard tag, otherwise adsh.
plabel The text presented on the line item, also known as a “preferred” label.
negating Flag to indicate whether the plabel is negating.